Age and Ethnic Disparities in Postmastectomy Immediate Breast Reconstruction: A cohort study from a Korean single center and National Cancer Database | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Age and Ethnic Disparities in Postmastectomy Immediate Breast Reconstruction: A cohort study from a Korean single center and National Cancer Database Soo-Young Lee, Madhav KC, Hyun Ho Han, Donald Lannin, Leah Kim, and 9 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6045529/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Purpose Postmastectomy immediate breast reconstruction (PMIBR) rates in breast cancer patients have increased over recent decades but remain less frequently performed and understudied in elderly patients. We aim to evaluate postmastectomy breast reconstruction trends by age in Korea and the United States, highlighting potential disparities related to age, geography and ethnicity. Methods This is a multi-cohort retrospective study analyzing three databases. The Asan Medical Center-Breast Cancer Registry (AMC-BCR) included 13,654 total mastectomy patients from 2001–2021. A subset of patients, separately collected as AMC-plastic surgery registry (AMC-PSR) was used to analyze age-related differences in comorbidities and complications. The National Cancer Database (NCDB) included 966,354 total mastectomy patients with stage 0–3 breast cancer from 2004–2020. Results PMIBR rates in AMC-BCR increased from 13–78% in younger patients (< 60 years) and from 0–28% in older patients (≥ 60 years). Patients living in a metropolitan area (49.4% vs. 46.6%, p = 0.001), with higher education (93.2% vs. 66.3%, p < 0.001), unmarried (12.5% vs. 5.1%, p < 0.001), and with no childbirth history (10.5% vs. 6.3%, p < 0.001) were more likely to undergo reconstruction. In the NCDB, the rates were 37% for young (< 60) Asian-Americans, 48% for young non-Asians, 14% for older (≥ 60) Asian-Americans, and 24% for older non-Asians in 2020. Asian-Americans had the lowest reconstruction rates across ethnicities. AMC-PSR data showed no significant difference in major complications by age. Conclusions Older patients exhibited lower reconstruction rates than the younger patients and demographic factors differed between age groups, suggesting disparities by age, ethnicity and cultural factors. postmastectomy reconstruction medical disparity age disparity ethnic disparity Figures Figure 1 Figure 2 Figure 3 Figure 4 Introduction Breast cancer is the most common malignancy in women, with its incidence increasing globally [ 1 ]. During 2016–2020 in the United States (U.S.), the median age at breast cancer diagnosis was 63 for white women and 59 for black women. Among them, 45.8% of newly diagnosed cases occurred in individuals aged ≥ 65 years, and 33% in women aged > 70 years [ 2 ]. In the European Union, 38.9% of breast cancer occurred in patients aged ≥ 70 years [ 3 ]. However, in Korea it was 40–49 years, which is less than that in Western countries [ 4 – 6 ]. About one third of newly diagnosed patients with breast cancer need to undergo total mastectomy (TM). Patients undergoing TM without reconstruction may experience high rates of depression, anxiety, stress, and body image dissatisfaction. Depression and related symptoms can significantly impact the quality of life (QOL), influence adherence to medical therapies, and potentially diminish survival outcomes [ 7 ]. Postmastectomy immediate breast reconstruction (PMIBR) provides aesthetic and psychological benefits and improves QOL and social and role functioning, and relieves fatigue, pain, and arm symptoms [ 8 – 10 ]. It is linked to reduced post-mastectomy depression and improved overall well-being [ 11 – 13 ]. The rates of patients receiving PMIBR have gradually increased, from 32.9–57.3% in women aged < 65 years and from 6.7–18.1% in women aged ≥ 65 years from 2004 to 2012, according to a study using the National Cancer Database (NCDB) [ 6 , 8 , 9 ]. Although the rates increased in both age groups, the underutilization in the elderly captured our attention. In a systematic review of 10 studies (2012–2020) including 466,134 women, 45% of younger (< 65 years) women and 10% of older women (≥ 65 years) received PMIBR [ 9 , 14 ]. This highlights a potential age-related medical disparity, with older individuals occasionally omitted from standard clinical practices. PMIBR may be less frequently performed in the older population for various reasons, including concerns about complications, prolonged hospital stay, or less offering of the procedure by clinicians [ 15 – 20 ]. However, studies have reported comparable complication rates between older and younger patients, suggesting that chronological age should not be a reason for avoiding PMIBR [ 21 – 22 ]. Previously reported articles exhibited heterogeneity about the definition of older age and had limitations due to their small sample sizes. It remains unclear why PMIBR is underutilized in the older women, compared to their younger counterparts. Globally, life expectancy has increased by more than 6 years, from 66.8 to 73.4 years, between 2000 and 2019 [ 23 ]. With the trend of extended life expectancy, a fit 70-year-old woman can potentially live at least 15 more years in high-income countries [ 24 ]. In a Korean nationwide cohort study, young adults (≤ 39 years) recovered from post mastectomy depression more rapidly than middle-aged and older adults [ 25 ]. Older age is reportedly associated with higher risk for depression, with those aged ≥ 70 years showing increased use of antidepressants [ 26 , 27 ]. While a relatively small number of older women undergo reconstruction, reported outcomes include satisfactory results and positive experience with good QOL [ 28 ]. However, the inclusion of older patients in clinical trials has been limited, resulting in a lack of robust evidence tailored to this demographic [ 23 ]. Therefore, our study addresses these concerns by examining PMIBR trends by age and its associated demographic factors using different set of cohorts. We extended our investigation to the American and Asian American population using the NCDB, offering a comprehensive perspective on the subject. Methods Patient database We collected patient information from three sets of cohorts from Korea and America to analyze PMIBR trends by age (Fig. 1 ). The Asan Medical Center-Breast Cancer Registry (AMC-BCR) is from a large single center, Asan Medical Center (AMC) Seoul, Korea. We analyzed 5,559 patients who underwent PMIBR out of 13,315 patients who underwent TM from 2001 to 2021, excluding male patients and patients in stage IV. Patient characteristics and demographic factors were retrospectively reviewed. The AMC-plastic surgery registry (PSR) is a separately collected subset of patients from AMC, consisting of 797 patients who underwent reconstruction with direct implant and 872 patients who underwent reconstruction with deep inferior epigastric perforator (DIEP) flap from 2010 to 2020. It was used to analyze PMIBR comorbidities and complications by age. For the American analysis, the NCDB, which includes 966,354 female patients with stage 0–3 breast cancer who underwent mastectomy from 2004 to 2020, was used. We divided patients into younger (< 60 years) and older (≥ 60 years) groups and compared patient characteristics and demographic factors. This study was reviewed and approved by the Institutional Review Board of AMC (2020 − 1245) Statistical analysis From the AMC-BCR, the demographic and clinical factors of patients who underwent TM without reconstruction and those who underwent PMIBR were compared. Variables with higher likelihood of receiving reconstruction were assessed and compared between patients aged < 60 years and those aged ≥ 60 years. In the AMC-BCR, the metropolitan residential region included six metropolitan cities of Korea (Busan, Daegu, Incheon, Gwangju, Daejeon, and Ulsan), one special city (Seoul), and one special self-governing city (Sejong). Using the NCDB, ethnicity, household incomes, cancer center type, location, and insurance status were added as variables for assessing the difference between younger and older patients receiving PMIBR. For all comparisons, chi-square test of independence was used for categorical variables, and independent t-test for continuous variables with normal distributions. Statistical analyses were performed using SPSS version 21.0 (IBM Corporation, Armonk, NY, USA). Results PMIBR trends by age in Korea (AMC-BCR) In 2001, PMIBR rates among patients who underwent TM with or without reconstruction was 11.5% (51/445), and it gradually increased to 66.9% (550/821) in 2021 at AMC. The increase in PMIBR cases was evident in all age groups, but more prominent in 40- and 50-year-olds (Fig. 2 ). No patients in their 60s received PMIBR in 2001; this changed since 2015 and gradually increased to 48 patients in 2021. The trends among younger (< 60 years) and older (≥ 60 years) age groups were compared in Fig. 3 . The PMIBR rate was 13% in 2001 and rapidly rose to 78% in 2021 in the younger age group, and from 1% in 2004 to 28% in 2021 in the older age group (Fig. 3 ). Trends of PMIBR rates by age and ethnicity in America (NCDB) Amongst different racial groups, a similar increasing trend was observed in Asian and non-Asian populations in America (Fig. 4 ). However, in all age groups, Asian Americans received less PMIBR than other races. In the younger (< 60 years) Asian population, the PMIBR rate increased from 18% in 2004 to 44% in 2015, remaining relatively stable thereafter. In the younger (< 60 years) non-Asian population, the rate increased from 29% in 2004 to 53% in 2015, with a slight fluctuation in subsequent years. In patients aged < 60 years, the PMIBR rates plateaued around 2015. For individuals aged ≥ 60 years, the PMIBR rates among Asian and non-Asian groups also displayed an upward trajectory. Among older (≥ 60 years) Asians, the rate increased from 5% in 2004 to 15% in 2013 and remained relatively steady thereafter. Among older (≥ 60 years) non-Asians, the rate increased from 7% in 2004 to 24% in 2020. The PMIBR rates of the older age group in Koreans exceeded that of Asian Americans in 2016 and became equivalent to that of non-Asians in America. These trends indicate a general increase in immediate breast reconstruction across various age and racial categories over the years, but its underutilization in the elderly and Asian Americans. Comparison of patients with and without PMIBR in Korea (AMC-BCR) Among the 13,315 patients who underwent mastectomy, 5,559 (41.7%) received PMIBR. The demographic and clinical parameters of patients who received PMIBR (PMIBR group) versus those who did not (TM only group) were compared in Table 1 . There were more patients aged ≥ 60 years in the TM only group than in the PMIBR group (26.1% vs.4.5%, p < 0.001). Living in a metropolitan area (46.6% vs. 49.4%, p = 0.001), having higher education (66.3% vs. 93.2%, p < 0.001), being unmarried (5.1% vs. 12.5%, p < 0.001), having no history of childbirth (6.3% vs. 10.5%, p < 0.001), and having lower stage and hormone receptor-positive HER2-negative breast cancer were more prevalent variables in the PMIBR group than in the TM only group. Comparison of younger (< 60) and older (≥ 60) patients who received PMIBR in Korea (AMC-BCR) Among 5,601 patients who underwent PMIBR, 95.5% were < 60 years, while 4.5% were ≥ 60 years. Body mass index (BMI) was significantly lower in younger patients than in older patients (mean BMI: 23.9 ± 9.4 vs. 25.7 ± 9.7, p < 0.001). When the demographic and clinical parameters were compared between younger and older patients, the most common factors in patients with reconstruction were all more common in the younger age group (Table 2 ). Younger patients had higher education levels (94.3% vs. 64.4%, p < 0.001), underwent axillary lymph node dissection more (37.6% vs. 21.1%, p < 0.001), and had higher T and N stage. The older group had a higher proportion of married patients (97.6% vs. 87.0%, p < 0.001) and birth history (91.5% vs. 89.4%, p = 0.001) than the younger group. Nipple sparing mastectomy (NSM) was more frequently performed in the younger group, whereas the older group more often underwent skin sparing mastectomy (SSM) (NSM, 54.8% vs. 48.4%; SSM, 44.3% vs. 51.2%, p = 0.024). Demographics and tumor characteristics of women receiving breast reconstruction in Americans In the NCDB, Asian Americans had the lowest breast reconstruction rate (3.79%) compared to white (77.76%), black (10.20%), and Hispanic Americans (6.42%). Patients receiving PMIBR were more likely to be white or non-Asian, have higher income and education, reside in a metropolitan area and in the Northeast, have less comorbidities, be treated in an academic center, and have a luminal subtype and lower stage. Additionally, patients with private health insurance were much more likely to undergo reconstruction (Table 3 ). Comorbidities and complications of immediate reconstruction A total of 797 patients who received PMIBR with direct implant were examined (Table 4 ). The prevalence of comorbidities and complication rates were reviewed. Hypertension was more prevalent in the older group (≥ 60 years) than in the younger group (< 60 years) (31.5% vs. 6.2%, p < 0.001). Diabetes and dyslipidemia was also more prevalent in the older group than in the younger group (diabetes, 13.7% vs. 1.9%, p < 0.001; dyslipidemia, 11.1% vs. 2.0%, p = 0.002). Regarding complications, seroma was more frequent in the older group than in the younger group (22.2% vs. 8.1%, p = 0.002), which was the only statistically significant difference between the two age groups among patients who had PMIBR with direct implant. A total of 872 patients who received PMIBR with DIEP were analyzed (Table 5 ). Hypertension was more frequent in the older group than in the younger group (27.9% vs. 7.2%, p < 0.001). In the early complication category, hematoma showed elevated prevalence rates in the older group (14.0% vs. 5.8%, p = 0.030). In the late complication category, fat necrosis was more prevalent in the older group than in the younger group (25.6% vs. 11.6%, p = 0.011). Discussion In this study, increasing trends of PMIBR rates and underutilization of PMIBR in older patients were observed over the last 20 years using two large cohorts in Korea and the U.S. Patient demographics and clinical parameters associated with the reconstruction recipients were also associated with the younger group compared to older group. Although a higher proportion of hypertension was observed in older patients, detrimetal complications, such as implant rupture, flap necrosis, and graft loss incidence, were similar between younger and older patients. The increasing trends of PMIBR align with findings from other studies. In a national database study of Australia, 41,880 women underwent mastectomy between 2010 and 2019, and breast reconstruction rates increased from 12.8–29% [ 24 ]. The increasing recognition of improved patient-reported outcomes, advancements in surgical techniques, and greater patient awareness all contribute to the rising popularity of breast reconstruction [ 29 ]. In the U.S., the rise in PMBR followed the enactment of the Women’s Health & Cancer Rights Act in 1998, which mandated insurance coverage for reconstruction and symmetry procedures [ 29 ]. In Korea, the National Health Insurance Service began covering autologous and implant reconstructions, nipple-areolar complex reconstructions, and additional operations required due to post-reconstruction complications or deformities since 2015. This public single-payer system led to notable increase in PMBR rates from 19.4% in 2015 to 53.4% in 2018 [ 30 ]. The differing timing of insurance likely explains the slight discrepancy in trends: in the NCDB, PMIBR rates plateaued for Asian and Non-Asian patients aged < 60 years in 2015, whereas in Korea, they continued to rise. Suggested reasons for theunderutilization of PMIBR in the older population include the absence of established treatment protocols, concerns about higher surgical risk, insufficient evidence on outcomes, and limited involvement of older-patients in the decision-making process [ 28 ]. A British review identified a woman's age as the most important factor in determining whether she will be offered PMBR. Older patients were less likely to be offered and choose to undergo reconstruction [ 28 ]. Owing to their under-representation in major clinical trials, older patients may receive either insufficient or excessive treatment. Efforts have recently been made to include or specifically focus on the older patients in clinical trials [ 31 ]. While these trials will undoubtedly contribute to informed oncologic decision-making for the elderly, there remains a need for more evidence and attention regarding surgical management, including breast reconstruction. In the review of five other studies comparing PMBR outcomes in older and younger patients, older patients had higher American Society of Anesthesiologists grades, a higher prevalence of hypertension, and a higher average BMI than younger patients. However, no difference was observed in hospital administration days, medical and surgical complication rates, and re-operations or revisions rates between older and younger patients. Older patients exhibited superior post-surgery overall QOL outcomes compared to their age-matched counterparts in the general population and patients who underwent mastectomy without reconstruction [ 28 ]. In another study reviewing more than 20 studies analyzing breast reconstruction in older women, the complication rates and patient-reported outcomes were not worse than those of younger women [ 22 ]. An emerging consensus exists that chronological age should not be a barrier to reconstruction [ 22 ]. Assessing function rather than focusing solely on chronological age has emerged as the most appropriate way to predict surgical outcomes in elderly patients, given their diverse range of physical conditions, capabilities, and expectations [ 32 , 33 ]. The disparities in PMIBR by age is influenced not only by lower proposal of the procedure by physicians but also factors such as awareness of the procedure, socioeconomic disadvantages, and systemic biases, which restrict healthcare access. Systemic biases are associated with residential regions, education levels, incomes, hospital types, and insurance types, which all vary by race and ethnicity. In Australia, breast reconstruction was less frequently performed in patients living in remote areas but more frequently performed in private hospitals [ 34 ]. In America, research indicated that large teaching-oriented and urban hospitals in the Northeast provided immediate breast reconstruction more [ 35 ]. Some experts suggest that a shortage of reconstructive surgeons in the Southern regions contributes to this regional variation [ 36 ]. A study investigating barriers to breast reconstruction in rural areas found that 21% of residents in upstate New York reside in counties without access to any form of breast reconstruction, and 44% in counties without access to microsurgical reconstruction [ 37 ]. In an observational cohort study examining the effect of insurance status on breast reconstruction rates, patients without health insurance or with government insurance (Medicare, Medicaid) were less likely to undergo breast reconstruction than those with private insurance [ 38 ]. Nevertheless, it is important to highlight that Asian Americans exhibit lower PMIBR rates than non-Asian Americans and even lower rates than Korean patients in the AMC-BCR, despite having a higher median household income on average compared to the general U.S. population [ 39 ]. The substantial underutilization of breast reconstruction in Asian Americans may be attributed to the fact that nearly half of Asian Americans reside in the Western region, where reconstruction procedures are less frequently performed [ 40 ]. Moreover, it should be considered that AMC might not fully represent the entire Korean population as it is one of the large volume centers located in the metropolitan area, actively engaging in academic research with access to microsurgery. Assuming a setting without regional limitations, insurance issues, communication barriers, or cultural differences, and with active consultation, Asian Americans could be more likely to opt for PMIBR. In a targeted review of the literature summarizing racial disparities in breast reconstruction for African American women, not only access to the procedure but also, comorbidities, outcomes, and literacy about reconstructive options differed [ 41 ]. A few studies have evaluated the effects of language barriers in patient-centered breast cancer care and decision-making. From a survey, physicians found it challenging, and in another study, patients felt disrespected and lacked clarity [ 42 , 43 ]. While making decisions about breast reconstruction require discussing various options and pros and cons, the present study could provide evidence to possible disparities to Asian Americans by sharing a Korean large center experience. The retrospective nature of this study presents a limitation, as it relies on available data and may be susceptible to inherent biases. Although the NCDB lacks comprehensive clinical information, such as breast size, BMI, smoking history, genetic predispositions, and diabetes, it provides valuable information on race, household income, cancer center type, and insurance type, which are not available in the AMC-BCR. Using the datasets and defining the threshold for old age as ≥ 60 years, we were able to gather a comparable number of elderly patients who underwent PMIBR and assess their surgical complication rates. Existing literature is limited to small retrospective studies or review articles with heterogeneous age criteria for defining the elderly population. In contrast, our study contributes significantly by providing a homogenous dataset comprising over 5,000 patients who underwent PMIBR at a single center. To overcome these limitations, future research could benefit from prospective designs with predefined protocols, offering a more robust approach to investigate the potential disparities and factors influencing PMBR. Efforts to lower the barrier for older women and Asian Americans and to mitigate disparities should be undertaken with data from further studies. Conclusion By highlighting trends of PMIBR by age, ethnicity, and culture, we provided additional evidence to the existing literature that PMIBR is underutilized in older patients and Asian Americans. Notable demographic and clinical differences were observed between younger and older patients, with negligible differences in complication rates. Further investigation into the factors contributing to these disparities, along with efforts to mitigate them, is necessary. Declarations Funding The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. Competing interest The authors declare that they have no conflict of interest. Authors contribution All authors contributed to the study conception and design. Material preparation and data collection were performed by Hyun Ho Han, Hyung Bae Kim, Byung Ho Son, Jong Won Lee, Sae Byul Lee, and Hee Jeong Kim. Analysis was performed by Soo-Young Lee and Madhav KC. The first draft of the manuscript was written by Soo-Young Lee and Tristen Park. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. We further confirm that the order of authors listed in the manuscript has been approved by all authors. The authors have no relevant financial or non-financial interests to disclose. Data availability The datasets analyzed during the current study are not publicly available due to protection of personal information of patients, but are available from the corresponding author on reasonable request. Ethical approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Consent to participate and publish Informed consent was waived because the study was based on retrospective clinical data. Acknowledgments We would like to thank Editage (www.editage.co.kr) for English language editing. References Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71(3), 209–249. National Institute of Health. (2023). Surveillance, Epidemiology, and End Results program. SEER Stat Fact Sheets: Female Breast Cancer. Retrieved from http://seer.cancer.gov/statfacts/html/breast.html (Accessed August 19, 2023). European Commission. (2023). Breast cancer statistics, European Cancer Information System. Retrieved from https://ecis.jrc.ec.europa.eu/pdf/Breast_cancer_2022-Oct_2023.pdf Yang, H., Ouyang, Q. C., Yan, M., Wang, X. J., Hu, X. C., Jiang, Z. F., et al. (2022). Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China. Annals of Translational Medicine, 10(15), 813. https://doi.org/10.21037/atm-22-302 Lim YX, Lim ZL, Ho PJ, Li J. (2022). Breast cancer in Asia: incidence, mortality, early detection, mammography programs, and risk-based screening initiatives. Cancers (Basel), 14, 4218. Kim MS, Kim SY, Kim JH, Park B, Choi HG. (2017). Depression in breast cancer patients who have undergone mastectomy: A national cohort study. PLOS ONE, 12(4), e0175395. https://doi.org/10.1371/journal.pone.0175395 Ho SS, So WK, Leung DY, Lai ET, Chan CW. (2013). Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: a comparative evaluation. European Journal of Oncology Nursing, 17(6), 877–882. Kim, M. K., Kim, T., Moon, H. G., Jin, U. S., Kim, K., Kim, J., et al. (2015). Effect of cosmetic outcome on quality of life after breast cancer surgery. European Journal of Surgical Oncology, 41(3), 426–432. https://doi.org/10.1016/j.ejso.2014.12.002 Churilla, T. M., Donnelly, P. E., Leatherman, E. R., Adonizio, C. S., & Peters, C. A. (2015). Total mastectomy or breast conservation therapy? How radiation oncologist accessibility determines treatment choice and quality: a SEER database analysis. The Breast Journal, 21(5), 473–480. Thakur, M., et al. (2023). Psychological distress and body image disturbances after modified radical mastectomy among breast cancer survivors: A cross-sectional study from a tertiary care centre in North India. The Lancet Regional Health - Southeast Asia, 7, 100077. Bellino S, Fenocchio M, Zizza M, et al. (2011). Quality of life of patients who undergo breast reconstruction after mastectomy: effects of personality characteristics. Plastic and Reconstructive Surgery, 127(1), 10–17. https://doi.org/10.1097/PRS.0b013e3181f956c0 Fernández-Delgado J, López-Pedraza MJ, Blasco JA, et al. (2008). Satisfaction with and psychological impact of immediate and deferred breast reconstruction. Annals of Oncology, 19(8), 1430–1434. https://doi.org/10.1093/annonc/mdn153 Rubino C, Figus A, Lorettu L, et al. (2007). Post-mastectomy reconstruction: a comparative analysis on psychosocial and psychopathological outcomes. Journal of Plastic, Reconstructive & Aesthetic Surgery, 60(5), 509–518. https://doi.org/10.1016/j.bjps.2006.06.013 Lee, R. X. N., Cardoso, M. J., Cheung, K. L., & Parks, R. M. (2022). Immediate breast reconstruction uptake in older women with primary breast cancer: a systematic review. The British Journal of Surgery, 109(11), 1063–1072. https://doi.org/10.1093/bjs/znac251 Jeevan, R., Browne, J. P., Gulliver-Clarke, C., et al. (2017). Association between age and access to immediate breast reconstruction in women undergoing mastectomy for breast cancer. Journal of British Surgery, 104(5), 555–561. Kruper, L., Holt, A., Xu, X. X., et al. (2011). Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California. Annals of Surgical Oncology, 18, 2158–2165. Morrow M, Scott SK, Menck HR, et al. (2001). Factors influencing the use of breast reconstruction post-mastectomy: a national cancer database study. Journal of the American College of Surgeons, 192, 1–8. Takahashi M, Kai I, Hisata M, et al. (2006). The association between breast surgeons’ attitudes toward breast reconstruction and their reconstruction-related information-giving behaviors: a nationwide survey in Japan. Plastic and Reconstructive Surgery, 118(6), 1507–1514. Bowman CC, Lennox PA, Clugston PA, Courtemanche DJ. (2006). Breast reconstruction in older women: should age be an exclusion criterion? Plastic and Reconstructive Surgery, 118(1), 16–22. Macmillan, R. D., & McCulley, S. J. (2016). Oncoplastic breast surgery: what, when and for whom? Current Breast Cancer Reports, 8, 112–117. Santosa, K. B., Qi, J., Kim, H. M., et al. (2016). Effect of patient age on outcomes in breast reconstruction: Results from a multicenter prospective study. Journal of the American College of Surgeons, 223(6), 745–754. https://doi.org/10.1016/j.jamcollsurg.2016.09.003 Mavioso, Carlos, Claudia Pereira, & Maria Joao Cardoso. (2023) Oncoplastic surgery and breast reconstruction in the elderly: an unsolved conundrum. Annals of Breast Surgery [Online], 7: n. pag. Web. 13 Feb. 2025 Biganzoli L, Battisti NML, Wildiers H, et al. (2021). Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol, 22, e32. Ho JY, Hendi AS. (2018). Recent trends in life expectancy across high-income countries: retrospective observational study. BMJ, 362, k2562. Kim MS, Kim SY, Kim JH, Park B, Choi HG. (2017). Depression in breast cancer patients who have undergone mastectomy: A national cohort study. PLOS ONE, 12(4), e0175395. https://doi.org/10.1371/journal.pone.0175395 Suppli, N. P., Johansen, C., Christensen, J., Kessing, L. V., Kroman, N., & Dalton, S. O. (2014). Increased risk for depression after breast cancer: a nationwide population-based cohort study of associated factors in Denmark, 1998-2011. Journal of Clinical Oncology, 32(34), 3831-3839. Hung YP, Liu CJ, Tsai CF, Hung MH, Tzeng CH, Liu CY, et al. (2013). Incidence and risk of mood disorders in patients with breast cancers in Taiwan: a nationwide population-based study. Psycho-oncology, 22(10), 2227–34. https://doi.org/10.1002/pon.3277 James, R., McCulley, S. J., & Macmillan, R. D. (2015). Oncoplastic and reconstructive breast surgery in the elderly. Journal of British Surgery, 102(5), 480-488. Panchal, H., & Matros, E. (2017). Current Trends in Postmastectomy Breast Reconstruction. Plastic and Reconstructive Surgery, 140(5S), 7S–13S. https://doi.org/10.1097/PRS.0000000000003941 Song, W. J., Kang, S. G., Kim, E. K., Song, S. Y., Lee, J. S., Lee, J. H., & Jin, U. S. (2020). Current status of and trends in post-mastectomy breast reconstruction in Korea. Archives of Plastic Surgery, 47(2), 118–125. https://doi.org/10.5999/aps.2019.01676 Kunkler IH, Williams LJ, Jack WJ, et al. (2015). Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomized controlled trial. Lancet Oncol, 16, 266-73. Lindgren, B. (2016).The Rise in Life Expectancy, Health Trends among the Elderly, and the Demand for Care - A Selected Literature Review (Working Paper No. 22521). National Bureau of Economic Research. DOI: 10.3386/w22521 Muss, H. B., & Busby-Whitehead, J. (2011). Older women with breast cancer: slow progress, great opportunity, now is the time. Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 29 (35), 4608–4610. https://doi.org/10.1200/JCO.2011.38.6888 Dayaratna, N., Nguyen, C. L., Spillane, A., Mak, C., Warrier, S. K., & Dusseldorp, J. R. (2023). Trends and variations in post-mastectomy breast reconstruction rates in Australia over 10 years. ANZ journal of surgery , 93 (1-2), 242–250. https://doi.org/10.1111/ans.18243 Habermann, E. B., Thomsen, K. M., Hieken, T. J., & Boughey, J. C. (2014). Impact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample. Annals of surgical oncology , 21 (10), 3290–3296. https://doi.org/10.1245/s10434-014-3924-y Chiu, A. S., Thomas, P., Killelea, B. K., Horowitz, N., Chagpar, A. B., & Lannin, D. R. (2017). Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB). American journal of surgery , 214 (5), 907–913. https://doi.org/10.1016/j.amjsurg.2017.07.008 Bhat, D., Heiman, A. J., Talwar, A. A., Dunne, M., Amanjee, K., & Ricci, J. A. (2020). Access to Breast Cancer Treatment and Reconstruction in Rural Populations: Do Women Have a Choice?. The Journal of surgical research , 254 , 223–231. https://doi.org/10.1016/j.jss.2020.04.035 Friedman-Eldar, O., Burke, J., de Castro Silva, I. et al. (2022). Stalled at the intersection: insurance status and disparities in post-mastectomy breast reconstruction. Breast Cancer Res Treat 194 , 327–335 . https://doi.org/10.1007/s10549-022-06639-8 American Community Survey (2021). "S0201: Selected Population Profile in the United States". American Community Survey 2021. United States Census Bureau. Retrieved February 8, 202 Abby Budiman and Neil G.Ruiz (2021). Key facts about Asian Americans. https://www.pewresearch.org/short-reads/2021/04/29/key-facts-about-asian-americans/ (last updated April 2021) Butler, P. D., Morris, M. P., & Momoh, A. O. (2021). Persistent Disparities in Postmastectomy Breast Reconstruction and Strategies for Mitigation. Annals of surgical oncology , 28 (11), 6099–6108. https://doi.org/10.1245/s10434-021-10487-z Schapira, M. M., Faghri, A., Jacobs, E. A., Fletcher, K. E., Ganschow, P. S., Gil, D., Smallwood, A. J., Walker, C. M., & Neuner, J. M. (2019). Communication and Shared Decision Making in the Breast Cancer Treatment Consultation: A Comparative Analysis of English- and Spanish-Speaking Patients. MDM policy & practice, 4(2), 2381468319881651. https://doi.org/10.1177/2381468319881651. Karliner, L. S., Hwang, E. S., Nickleach, D., Kaplan, C. P. (2011). Language barriers and patient-centered breast cancer care. Patient Education and Counseling, 84(2), 223-228. https://doi.org/10.1016/j.pec.2010.07.009 Tables Table 1 Patient demographics and tumor characteristics by receipt of breast reconstruction 2001–2021, AMC-BCR (N = 13,315) Characteristics Total patients N (%) TM only (N = 7,756) PMIBR (N = 5,559) p-value Age < 0.001 <60 11,042 (82.9) 5,734 (73.9) 5,308 (95.5) ≥ 60 2,273 (17.1) 2,022 (26.1) 251 (4.5) Residential region 0.001 Metropolitan 6,257 (47.8) 3,545 (46.6) 2,712 (49.4) Non-metropolitan 6,844 (52.2) 4,066 (53.4) 2,779 (50.6) Unknown 214 Education < 0.001 High school degree 8,095 (76.3) 4,424 (66.3) 3671 (93.2) Less 2,518 (23.7) 2,249 (33.7) 269 (6.8) Unknown 2,702 Marital status < 0.001 Yes 11,974 (91.8) 7,189 (94.9) 4,785 (87.5) No 1,068 (8.2) 3,84 (5.1) 684 (12.5) Unknown 273 Parity < 0.001 More than one child 11,419 (92.0) 6,786 (93.7) 4,633 (89.5) No 998 (8.0) 453 (6.3) 545 (10.5) Unknown 898 Stage < 0.001 0 1,203 (9.0) 459 (5.9) 744 (13.4) 1 4,4217 (31.7) 2,073 (26.7) 2,144 (38.6) 2 5,357 (40.2) 3,396 (43.8) 1,961 (35.3) 3 2,538 (19.1) 1,828 (23.6) 710 (12.8) Subtype < 0.001 HR+/HER2- 6,262 (53.7) 3,330 (48.8) 2,932 (60.6) HR+/HER2+ 1,756 (15.1)) 971 (14.2) 785 (16.2) HR-/HER2+ 2,145 (18.4) 1,391 (20.4) 754 (15.6) HR-/HER2- 1,504 (12.9) 1,136 (16.6) 368 (7.6) Unknown 1,648 AMC-BCR, Asan medical center-breast cancer registry; HR, hormone receptor; HER2, Human epidermal growth factor receptor2 Table 2 Comparison of baseline characteristics of young and old patients receiving PMIBR (N = 5,559) Characteristics Total patients N = 5,559 N (%) Patients < 60 years old N = 5,308 N (%) Patients ≥ 60 years old N = 251 p-value Age at initial surgery (years), mean ± SD 44.6 ± 8.3 43.7 ± 7.4 62.9 ± 2.9 < 0.001 Body mass index (kg/m 2 ) 24.0 ± 9.4 23.9 ± 9.4 25.7 ± 9.7 < 0.001 Residential region 0.697 Metropolitan 2,712 (49.4) 25,866 (49.3) 126 (50.6) Non-metropolitan 2,779 (50.6) 2,656 (50.7) 123 (49.4) Unknown 68 Education < 0.001 High school degree 3,671 (93.2) 3,575 (94.3) 96 (64.4) Less 269 (6.8) 216 (5.7) 53 (35.6) Unknown 1,619 Marital status < 0.001 Yes 4,785 (87.5) 4543 (87.0) 242 (97.6) No 684 (12.5) 678 (13.0) 6 (2.4) Unknown 60 Parity 0.329 Yes 4,633 (89.5) 4,417 (89.4) 216 (91.5) No 545 (10.5) 525 (10.6) 20 (8.5) Unknown 381 Axillary staging < 0.001 No axillary surgery 67 (1.2) 66 (1.2) 1 (0.4) SLNB alone 3,444 (62.0) 3,247 (61.2) 197 (78.5) Axillary lymph node dissection with/without SLNB 2,048 (36.8) 1,995 (37.6) 53 (21.1) Clinical T stage T0 989 (17.8) 920 (17.3) 69 (27.5) 0.001 T1 2,591 (46.6) 2,474 (46.6) 117 (46.6) T2 1,619 (29.1) 1,557 (29.3) 62 (24.7) T3 350 (6.3) 347 (6.5) 3 (1.2) T4 10 (0.2) 10 (0.2) 0 Clinical N stage N0 3,750 (67.5) 3,550 (66.9) 200 (79.7) < 0.001 N1 1,346 (24.2) 1,305 (24.6) 41 (16.3) N2 344 (6.2) 335 (6.3) 9 (3.6) N3 119 (2.1) 118 (2.2) 1 (0.4) Clinical tumor size (cm) 2.2 ± 2.0 2.2 ± 2.1 1.7 ± 1.6 < 0.001 Neoadjuvant chemotherapy Yes 1,443 (26.0) 3,931 (74.1) 185 (73.7) 0.901 No 4,116 (74.0) 1,377 (25.9) 66 (26.3) Mastectomy type 0.022 MRM 48 (0.9) 47 (0.9) 1 (0.4) SSM 2,479 (44.6) 2350 (44.3) 129 (51.2) NSM 3,032 (54.5) 2911 (54.8) 121 (48.4) Reconstruction type 0.072 Implant 1,771 (31.9) 1678 (31.6) 93 (37.1) Autologous 3,788 (68.1) 3630 (68.4) 158 (62.9) Histologic grade 1 245 (5.4) 237 (5.4) 8 (4.3) 0.519 2 2,934 (64.6) 2,818 (64.7) 116 (62.4) 3 136 (30.0) 1,299 (29.9) 62 (33.3) Unknown 1,019 Nuclear grade 0.639 1 219 (4.2) 208 (4.2) 11 (4.8) 2 3,394 (65.6) 3,259 (65.9) 135 (59.5) 3 1,561 (30.2) 1,480 (29.9) 81 (35.7) Unknown 385 Lymphovascular invasion < 0.001 No 3,692 (74.3) 3,491 (73.6) 201 (88.5) Yes 1,276 (25.7) 1,250 (26.4) 26 (11.5) Unknown 591 Hormone receptor < 0.001 Negative 1,151 (22.1) 1,074 (21.5) 77 (35.3) Positive 4,052 (77.9) 3,911 (78.5) 141 (64.7) Unknown 356 HER2 0.233 Negative 3,300 (63.5) 3,166 (63.6) 134 (61.8) Positive 1,540 (29.7) 1,464 (29.4) 76 (35.0) Equivocal 353 (6.8) 346 (7.0) 7 (3.2) Unknown 366 Ki-67 0.002 ≤ 20 2,429 (58.1) 2,325 (58.7) 104 (48.1) > 20 1,751 (41.9) 1,639 (41.3) 112 (51.9) Unknown 1,379 Adjuvant chemotherapy 0.012 No 2,220 (44.6) 2,113 (44.2) 107 (53.5) Yes 2,760 (55.4) 2,667 (55.8) 93 (46.5) Unknown 579 Adjuvant radiotherapy 0.033 No 3,929 (78.9) 3,759 (78.7) 170 (85.0) Yes 1,050 (21.1) 1,020 (21.3) 30 (15.0) Unknown 580 Adjuvant endocrine therapy < 0.001 No 1,612 (32.5) 1,518 (31.9) 94 (47.0) Yes 3,354 (67.5) 3,248 (68.1) 106 (53.0) Unknown 593 PMIBR, postmastectomy immediate breast reconstruction ;SD, standard deviation; SLNB, sentinel lymph node biopsy; MRM, modified radical mastectomy; SSM, skin sparing mastectomy; NSM, nipple sparing mastectomy; HER2, human epidermal growth factor receptor 2 Table 3 Demographics and tumor characteristics of women receiving breast reconstruction by age: NCDB 2004–2020 (N = 966,354) Characteristics Total < 60 years ≥ 60 years p-value n (%) n (%) Race classification 1 Asian 12,588 3.79 10,988 87.29 1,600 12.71 < .0001 Non-Asian 319,644 96.21 248,757 77.82 70,887 22.18 Race classification 2 Korean 876 0.26 764 87.21 112 12.79 < .0001 Other Asians 11,712 3.53 10,224 87.30 1,488 12.70 Non-Asian 319,644 96.21 248,757 77.82 70,887 22.18 Race classification 3 White 258,355 77.76 198,191 76.71 60,164 23.29 < .0001 Black 33,876 10.20 27,609 81.50 6,267 18.50 Asian 12,588 3.79 10,988 87.29 1,600 12.71 Hispanic 21,316 6.42 17,910 84.02 3,406 15.98 Native 778 0.23 635 81.62 143 18.38 Other 5,319 1.60 4,412 82.95 907 17.05 Median household income <$46,277 29,702 8.94 22,672 76.33 (9.98) 7,030 23.67 (11.2) < .0001 $46,277–$57,856 47,588 14.32 36,389 76.47 (16.02) 11,199 23.53 (17.87) $57,857–$74,062 65,469 19.71 50,715 77.46 (22.32) 14,754 22.54 (23.55) $74,063+ 14,7079 44.27 117,413 79.83 (51.68) 29,666 20.17 (47.35) Unknown 42,394 12.76 32,556 76.79 9,838 23.21 High school degree (%) ≥15.3% 42,859 12.90 33,423 77.98 9,436 22.02 < .0001 9.1–15.2% 69,137 20.81 53,593 77.52 15,544 22.48 5.0–9.0% 87,943 26.47 68,883 78.33 19,060 21.67 <5.0% 90,398 27.21 71,646 79.26 18,752 20.74 Unknown 41,895 12.61 32,200 76.86 9,695 23.14 Urban/Rural Metro 290,660 87.49 227,884 78.40 62,776 21.60 < .0001 Urban 27,866 8.39 21,133 75.84 (8.40) 6,733 24.16 (9.56) Rural 3,413 1.03 2,524 73.95 (1.00) 889 26.05 (1.26) Unknown 10,293 3.10 8,204 79.70 2,089 20.30 Cancer center type Community 10,937 3.29 7,981 72.97 2,956 27.03 < .0001 Comprehensive 108,821 32.75 79,591 73.14 29,230 26.86 Academic 97,066 29.22 74,412 76.66 22,654 23.34 Integrated network 70,259 21.15 52,612 74.88 17,647 25.12 Unknown 45,149 13.59 45,149 100.00 0 0.00 Cancer center location Northeast 64,563 19.43 49,816 77.16 (23.21) 14,747 22.84 (20.34) < .0001 Midwest 71,915 21.65 54,729 76.10 (25.50) 17,186 23.90 (23.71) South 107,632 32.40 78,198 72.65 (36.44) 29,434 27.35 (37.85) West 42,973 12.93 31,853 74.12 (14.84) 11,120 25.88 (15.34) Unknown 45,149 13.59 45,149 100.00 0 0.00 Multi facility treatment No 245,543 73.91 190,871 77.73 54,672 22.27 < .0001 Yes 86,689 26.09 68,874 79.45 17,815 20.55 Charlson Deyo score 0 295,930 89.07 235,791 79.68 60,139 20.32 < .0001 1 30,904 9.30 20,964 67.84 9,940 32.16 2+ 5,398 1.62 2,990 55.39 2,408 44.61 Insurance status Private 260,912 78.53 225,820 86.55 35,092 13.45 < .0001 Medicaid 20,132 6.06 18,161 90.21 1,971 9.79 Medicare 39,304 11.83 5,779 14.70 33,525 85.30 Other Goverment 4,283 1.29 3,537 82.58 746 17.42 No insurance 4,430 1.33 3,929 88.69 501 11.31 Unknown 3,171 0.95 2,519 79.44 652 20.56 Stage 0 64,882 19.53 51,159 78.85 13,723 21.15 < .0001 I 132,385 39.8 100,373 75.82 32,012 24.18 II 98,665 29.70 78,931 80.00 19,734 20.00 III 36,300 10.93 29,282 80.67 7,018 19.33 Subtype ER/PR+, HER2- 144,018 43.35 107,733 74.81 36,285 25.19 < .0001 ER/PR+, HER2+ 28,376 8.54 23,632 83.28 4,744 16.72 ER/PR-, HER2+ 12,634 3.80 10,254 81.16 2,380 18.84 ER/PR-, HER2 - 25,737 7.75 21,296 82.74 4,441 17.26 Unknown 121,467 36.56 96,830 79.72 24,637 20.28 NCDB, national cancer database; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2 Table 4 Comorbidities and complications of immediate reconstruction with direct implant, AMC-PSR Total patients N = 797 N (%) Patients < 60 years old N = 743 N (%) Patients ≥ 60 years old N = 54 N (%) p-value Age 44.6 ± 9.2 43.3 ± 7.8 63.6 ± 3.0 Comorbidities Hypertension 63 (7.9) 46 (6.2) 17 (31.5) < 0.001 Diabetes 21 (2.6) 14 (1.9) 7 (13.7) < 0.001 CAD 3 (0.4) 3 (0.4) 0 0.640 PVD 0 Dyslipidemia 21 (2.6) 15 (2.0) 6 (11.1) 0.002 Current smoking 18 (2.3) 17 (2.3) 1 (1.9) 0.835 Breast operation type 0.026 NSM 602 (75.5) 568 (76.4) 34 (63.0) SSM 195 (24.5) 175 (23.6) 20 (37.0) Early complication Hematoma 20 (2.5) 20 (2.7) 0 0.222 Seroma 72 (9.0) 60 (8.1) 12 (22.2) 0.002 Infection 35 (4.4) 31 (4.2) 4 (7.4) 0.263 Flap necrosis 62 (7.8) 56 (7.5) 6 (11.1) 0.344 Wound dehiscence 43 (5.4) 37 (5.0) 6 (11.1) 0.054 Implant failure 10 (1.3) 9 (1.2) 1 (1.9) 0.683 Late complication Seroma 9 (1.1) 8 (1.1) 1 (1.9) 0.603 Infection 11 (1.4) 9 (1.2) 2 (3.7) 0.130 Capsular contracture 67 (8.4) 60 (8.1) 7 (13.0) 0.211 Animation 34 (4.3) 32 (4.3) 2 (3.7) 0.832 Implant shift or rotation 74 (9.3) 72 (9.7) 2 (3.2) 0.143 Implant failure 6 (0.8) 5 (0.7) 1 (1.9) 0.333 Implant rupture 9 (1.1) 9 (1.2) 0 0.416 Implant change 15 (1.9) 15 (2.0) 0 0.292 AMC-PSR, Asan medical center plastic surgery registry; CAD, coronary artery disease; PAD, peripheral artery disease; NSM, nipple sparing mastectomy; SSM, skin sparing mastectomy Table 5 Comorbidities and complications of immediate reconstruction with DIEP, AMC-PSR Total patients N = 872 N (%) Patients < 60 years old N = 829 N (%) Patients ≥ 60 years old N = 43 N (%) p-value Age 46.9 ± 7.6 46.0 ± 6.8 62.9 ± 2.2 Comorbidities Hypertension 72 (8.3) 60 (7.2) 12 (27.9) < 0.001 Diabetes 19 (2.2) 17 (2.1) 2 (4.7) 0.255 CAD 0 PVD 0 Dyslipidemia 23 (2.6) 21 (2.5) 2 (4.7) 0.315 Current smoking 18 (2.1) 17 (2.1) 1 (2.3) 0.902 Breast operation type NSM 460 438 (52.8) 22 (51.2) 0.830 SSM 407 386 (46.6) 21 (48.8) Other 5 5 (0.6) Early complication Early revision 29 (3.3) 28 (3.4) 1 (2.3) 0.708 Partial loss 1 (0.1) 1 (0.1) 0 0.820 Total loss 5 (0.6) 5 (0.6) 0 0.610 Hematoma 54 (6.2) 48 (5.8) 6 (14.0) 0.030 Seroma 35 (4.0) 31 (3.7) 4 (9.3) 0.070 Infection 8 (0.9) 8 (1.0) 0 0.518 Flap necrosis 114 (13.1) 106 (12.8) 8 (18.6) 0.270 Wound dehiscence 23 (2.6) 23 (2.8) 0 0.268 Late complication Fat necrosis 107 (12.3) 96 (11.6) 11 (25.6) 0.011 Volume loss 22 (2.5) 22 (2.7) 0 0.279 Flap contracture or shrinkage 14 (1.6) 13 (1.6) 1 0.510 DIEP, deep inferior epigastric perforator; AMC-PSR, Asan medical center plastic surgery registry; CAD, coronary artery disease; PAD, peripheral artery disease; NSM, nipple sparing mastectomy; SSM, skin sparing mastectomy Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6045529","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":417742846,"identity":"0ae7fc2d-03d2-458d-89ce-143a6e9dafe8","order_by":0,"name":"Soo-Young Lee","email":"","orcid":"","institution":"Inha University Hospital","correspondingAuthor":false,"prefix":"","firstName":"Soo-Young","middleName":"","lastName":"Lee","suffix":""},{"id":417742847,"identity":"8ea9cdf0-2a15-4715-851e-dbad84f8a62c","order_by":1,"name":"Madhav KC","email":"","orcid":"","institution":"University of Nebraska Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Madhav","middleName":"","lastName":"KC","suffix":""},{"id":417742848,"identity":"e049de16-30e5-4bd2-9fac-b4a19f68a7b5","order_by":2,"name":"Hyun Ho Han","email":"","orcid":"","institution":"University of Ulsan College of Medicine, Asan Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Hyun","middleName":"Ho","lastName":"Han","suffix":""},{"id":417742849,"identity":"36931075-907c-4214-a0dd-8ecc4a227ce5","order_by":3,"name":"Donald Lannin","email":"","orcid":"","institution":"Yale School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Donald","middleName":"","lastName":"Lannin","suffix":""},{"id":417742850,"identity":"d28fe5b0-bffb-4810-841c-2dfb95992bae","order_by":4,"name":"Leah Kim","email":"","orcid":"","institution":"Yale School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Leah","middleName":"","lastName":"Kim","suffix":""},{"id":417742851,"identity":"91baa0f8-93d7-47bc-ad66-738a521f2480","order_by":5,"name":"Mehra Golshan","email":"","orcid":"","institution":"Yale School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Mehra","middleName":"","lastName":"Golshan","suffix":""},{"id":417742852,"identity":"2b7e1c79-6eb1-42e9-92a7-3ac664d4fe07","order_by":6,"name":"Eric Schneider","email":"","orcid":"","institution":"Yale School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Eric","middleName":"","lastName":"Schneider","suffix":""},{"id":417742853,"identity":"a6a026f9-df2f-44b8-b428-117d1c1f001b","order_by":7,"name":"Rachel A. Greenup","email":"","orcid":"","institution":"Yale School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Rachel","middleName":"A.","lastName":"Greenup","suffix":""},{"id":417742854,"identity":"f2abe07d-269c-404f-a8f2-759d29f6c2cc","order_by":8,"name":"Hyung Bae Kim","email":"","orcid":"","institution":"University of Ulsan College of Medicine, Asan Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Hyung","middleName":"Bae","lastName":"Kim","suffix":""},{"id":417742855,"identity":"81c55e47-7e4e-48ac-b5ac-9f921316c629","order_by":9,"name":"Byung Ho Son","email":"","orcid":"","institution":"University of Ulsan College of Medicine, Asan Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Byung","middleName":"Ho","lastName":"Son","suffix":""},{"id":417742856,"identity":"6451584d-26d4-4baf-9d4c-c9e1aa4fd7c8","order_by":10,"name":"Jong Won Lee","email":"","orcid":"","institution":"University of Ulsan College of Medicine, Asan Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Jong","middleName":"Won","lastName":"Lee","suffix":""},{"id":417742857,"identity":"264174c8-635b-4154-8d10-5398f134e27c","order_by":11,"name":"Sae Byul Lee","email":"","orcid":"","institution":"University of Ulsan College of Medicine, Asan Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Sae","middleName":"Byul","lastName":"Lee","suffix":""},{"id":417742858,"identity":"583df34e-6a16-4fe9-a70a-deb44b7fa55b","order_by":12,"name":"Tristen S. Park","email":"","orcid":"","institution":"The Mount Sinai Hospital","correspondingAuthor":false,"prefix":"","firstName":"Tristen","middleName":"S.","lastName":"Park","suffix":""},{"id":417742859,"identity":"c6e860f3-c757-43d9-beee-f6308244e752","order_by":13,"name":"Hee Jeong Kim","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABAUlEQVRIiWNgGAWjYBACAyhmkGBmYAAiGyCTsfEAKVrSQFoaCGoBAwkGsJbDYA5eLebszQcKPlTcsZvZzp3AXLjnvN3a9sNAW2psonFpsew5lmA448yz5NnMvBuYZzy7nbztTCJQy7G03AZcDruRY2DM23Y4WQ6khefA7WSzA0AtjA2HcWu5//6D8V+ElnPJZucfEtByg4fBmLHtsJ00RMsBO7MbhGw5k2Zg2HPmcIJkM++GwzMOJCeY3QDakoDPL8cPPzP4UXHYXuL82Y2PCw7Y2ZudT3/44EONDU4tQMAGiptEkIIDMAZDAm7lIMD8AEjYw3j2uBWOglEwCkbBSAUAePdmvLEI41wAAAAASUVORK5CYII=","orcid":"","institution":"University of Ulsan College of Medicine, Asan Medical Center","correspondingAuthor":true,"prefix":"","firstName":"Hee","middleName":"Jeong","lastName":"Kim","suffix":""}],"badges":[],"createdAt":"2025-02-17 07:53:12","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-6045529/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-6045529/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":76861100,"identity":"b5193010-5ae5-4050-ad97-f483c899b9cd","added_by":"auto","created_at":"2025-02-21 13:39:32","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":38818,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003ePatient database sets\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003ePMIBR, postmastectomy immediate breast reconstruction ; DIEP, deep inferior epigastric perforator\u003c/p\u003e","description":"","filename":"1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-6045529/v1/fa97156f7c8df59ef57f173c.jpg"},{"id":76861114,"identity":"b333507b-82d2-485b-aa19-a291abb86267","added_by":"auto","created_at":"2025-02-21 13:39:33","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":92044,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eTrends of postmastectomy immediate breast reconstruction rates and number of reconstructions by age, Asan Medical Center, 2001-2021\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-6045529/v1/24b5a3e72ce4eb8594ce18b4.jpg"},{"id":76861112,"identity":"19e2bca7-6e2c-4380-a527-edb04ac20917","added_by":"auto","created_at":"2025-02-21 13:39:32","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":95321,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eTrends of the percentage of postmastectomy immediate breast reconstruction in younger and older patients, Asan Medical Center, 2001–2021\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-6045529/v1/efb7768c33c86415d3669085.jpg"},{"id":76861116,"identity":"fd68d1ce-8829-453f-8ddb-7df256e8deb2","added_by":"auto","created_at":"2025-02-21 13:39:33","extension":"jpg","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":71615,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eBreast reconstruction trends by ethnicity and age, NCDB 2004–2020 and in Koreans (Asan Medical Center)\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-6045529/v1/cc395df4e7a35bc617e9da4c.jpg"},{"id":90272531,"identity":"4ce80520-8fa5-4d44-a7a2-e32d4e04bbca","added_by":"auto","created_at":"2025-09-01 01:01:35","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3421933,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6045529/v1/61823e1e-da0f-4128-931a-82cdef6cfc72.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Age and Ethnic Disparities in Postmastectomy Immediate Breast Reconstruction: A cohort study from a Korean single center and National Cancer Database","fulltext":[{"header":"Introduction","content":"\u003cp\u003eBreast cancer is the most common malignancy in women, with its incidence increasing globally [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. During 2016\u0026ndash;2020 in the United States (U.S.), the median age at breast cancer diagnosis was 63 for white women and 59 for black women. Among them, 45.8% of newly diagnosed cases occurred in individuals aged\u0026thinsp;\u0026ge;\u0026thinsp;65 years, and 33% in women aged\u0026thinsp;\u0026gt;\u0026thinsp;70 years [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e]. In the European Union, 38.9% of breast cancer occurred in patients aged\u0026thinsp;\u0026ge;\u0026thinsp;70 years [\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. However, in Korea it was 40\u0026ndash;49 years, which is less than that in Western countries [\u003cspan additionalcitationids=\"CR5\" citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eAbout one third of newly diagnosed patients with breast cancer need to undergo total mastectomy (TM). Patients undergoing TM without reconstruction may experience high rates of depression, anxiety, stress, and body image dissatisfaction. Depression and related symptoms can significantly impact the quality of life (QOL), influence adherence to medical therapies, and potentially diminish survival outcomes [\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e]. Postmastectomy immediate breast reconstruction (PMIBR) provides aesthetic and psychological benefits and improves QOL and social and role functioning, and relieves fatigue, pain, and arm symptoms [\u003cspan additionalcitationids=\"CR9\" citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. It is linked to reduced post-mastectomy depression and improved overall well-being [\u003cspan additionalcitationids=\"CR12\" citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eThe rates of patients receiving PMIBR have gradually increased, from 32.9\u0026ndash;57.3% in women aged\u0026thinsp;\u0026lt;\u0026thinsp;65 years and from 6.7\u0026ndash;18.1% in women aged\u0026thinsp;\u0026ge;\u0026thinsp;65 years from 2004 to 2012, according to a study using the National Cancer Database (NCDB) [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e, \u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e, \u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. Although the rates increased in both age groups, the underutilization in the elderly captured our attention. In a systematic review of 10 studies (2012\u0026ndash;2020) including 466,134 women, 45% of younger (\u0026lt;\u0026thinsp;65 years) women and 10% of older women (\u0026ge;\u0026thinsp;65 years) received PMIBR [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e, \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. This highlights a potential age-related medical disparity, with older individuals occasionally omitted from standard clinical practices.\u003c/p\u003e \u003cp\u003ePMIBR may be less frequently performed in the older population for various reasons, including concerns about complications, prolonged hospital stay, or less offering of the procedure by clinicians [\u003cspan additionalcitationids=\"CR16 CR17 CR18 CR19\" citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e]. However, studies have reported comparable complication rates between older and younger patients, suggesting that chronological age should not be a reason for avoiding PMIBR [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. Previously reported articles exhibited heterogeneity about the definition of older age and had limitations due to their small sample sizes. It remains unclear why PMIBR is underutilized in the older women, compared to their younger counterparts.\u003c/p\u003e \u003cp\u003eGlobally, life expectancy has increased by more than 6 years, from 66.8 to 73.4 years, between 2000 and 2019 [\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e]. With the trend of extended life expectancy, a fit 70-year-old woman can potentially live at least 15 more years in high-income countries [\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e]. In a Korean nationwide cohort study, young adults (\u0026le;\u0026thinsp;39 years) recovered from post mastectomy depression more rapidly than middle-aged and older adults [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e]. Older age is reportedly associated with higher risk for depression, with those aged\u0026thinsp;\u0026ge;\u0026thinsp;70 years showing increased use of antidepressants [\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e, \u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e]. While a relatively small number of older women undergo reconstruction, reported outcomes include satisfactory results and positive experience with good QOL [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. However, the inclusion of older patients in clinical trials has been limited, resulting in a lack of robust evidence tailored to this demographic [\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e]. Therefore, our study addresses these concerns by examining PMIBR trends by age and its associated demographic factors using different set of cohorts. We extended our investigation to the American and Asian American population using the NCDB, offering a comprehensive perspective on the subject.\u003c/p\u003e"},{"header":"Methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003ePatient database\u003c/h2\u003e \u003cp\u003eWe collected patient information from three sets of cohorts from Korea and America to analyze PMIBR trends by age (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e). The Asan Medical Center-Breast Cancer Registry (AMC-BCR) is from a large single center, Asan Medical Center (AMC) Seoul, Korea. We analyzed 5,559 patients who underwent PMIBR out of 13,315 patients who underwent TM from 2001 to 2021, excluding male patients and patients in stage IV. Patient characteristics and demographic factors were retrospectively reviewed. The AMC-plastic surgery registry (PSR) is a separately collected subset of patients from AMC, consisting of 797 patients who underwent reconstruction with direct implant and 872 patients who underwent reconstruction with deep inferior epigastric perforator (DIEP) flap from 2010 to 2020. It was used to analyze PMIBR comorbidities and complications by age. For the American analysis, the NCDB, which includes 966,354 female patients with stage 0\u0026ndash;3 breast cancer who underwent mastectomy from 2004 to 2020, was used. We divided patients into younger (\u0026lt;\u0026thinsp;60 years) and older (\u0026ge;\u0026thinsp;60 years) groups and compared patient characteristics and demographic factors.\u003c/p\u003e \u003cp\u003e This study was reviewed and approved by the Institutional Review Board of AMC (2020\u0026thinsp;\u0026minus;\u0026thinsp;1245)\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003eStatistical analysis\u003c/h2\u003e \u003cp\u003eFrom the AMC-BCR, the demographic and clinical factors of patients who underwent TM without reconstruction and those who underwent PMIBR were compared. Variables with higher likelihood of receiving reconstruction were assessed and compared between patients aged\u0026thinsp;\u0026lt;\u0026thinsp;60 years and those aged\u0026thinsp;\u0026ge;\u0026thinsp;60 years. In the AMC-BCR, the metropolitan residential region included six metropolitan cities of Korea (Busan, Daegu, Incheon, Gwangju, Daejeon, and Ulsan), one special city (Seoul), and one special self-governing city (Sejong).\u003c/p\u003e \u003cp\u003eUsing the NCDB, ethnicity, household incomes, cancer center type, location, and insurance status were added as variables for assessing the difference between younger and older patients receiving PMIBR.\u003c/p\u003e \u003cp\u003eFor all comparisons, chi-square test of independence was used for categorical variables, and independent t-test for continuous variables with normal distributions. Statistical analyses were performed using SPSS version 21.0 (IBM Corporation, Armonk, NY, USA).\u003c/p\u003e \u003c/div\u003e"},{"header":"Results","content":"\u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003ePMIBR trends by age in Korea (AMC-BCR)\u003c/h2\u003e \u003cp\u003eIn 2001, PMIBR rates among patients who underwent TM with or without reconstruction was 11.5% (51/445), and it gradually increased to 66.9% (550/821) in 2021 at AMC. The increase in PMIBR cases was evident in all age groups, but more prominent in 40- and 50-year-olds (Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e). No patients in their 60s received PMIBR in 2001; this changed since 2015 and gradually increased to 48 patients in 2021.\u003c/p\u003e \u003cp\u003eThe trends among younger (\u0026lt;\u0026thinsp;60 years) and older (\u0026ge;\u0026thinsp;60 years) age groups were compared in Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003e. The PMIBR rate was 13% in 2001 and rapidly rose to 78% in 2021 in the younger age group, and from 1% in 2004 to 28% in 2021 in the older age group (Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003e).\u003c/p\u003e \u003c/div\u003e\n\u003ch3\u003eTrends of PMIBR rates by age and ethnicity in America (NCDB)\u003c/h3\u003e\n\u003cp\u003eAmongst different racial groups, a similar increasing trend was observed in Asian and non-Asian populations in America (Fig.\u0026nbsp;\u003cspan refid=\"Fig4\" class=\"InternalRef\"\u003e4\u003c/span\u003e). However, in all age groups, Asian Americans received less PMIBR than other races.\u003c/p\u003e \u003cp\u003eIn the younger (\u0026lt;\u0026thinsp;60 years) Asian population, the PMIBR rate increased from 18% in 2004 to 44% in 2015, remaining relatively stable thereafter. In the younger (\u0026lt;\u0026thinsp;60 years) non-Asian population, the rate increased from 29% in 2004 to 53% in 2015, with a slight fluctuation in subsequent years. In patients aged\u0026thinsp;\u0026lt;\u0026thinsp;60 years, the PMIBR rates plateaued around 2015.\u003c/p\u003e \u003cp\u003eFor individuals aged\u0026thinsp;\u0026ge;\u0026thinsp;60 years, the PMIBR rates among Asian and non-Asian groups also displayed an upward trajectory. Among older (\u0026ge;\u0026thinsp;60 years) Asians, the rate increased from 5% in 2004 to 15% in 2013 and remained relatively steady thereafter. Among older (\u0026ge;\u0026thinsp;60 years) non-Asians, the rate increased from 7% in 2004 to 24% in 2020. The PMIBR rates of the older age group in Koreans exceeded that of Asian Americans in 2016 and became equivalent to that of non-Asians in America.\u003c/p\u003e \u003cp\u003eThese trends indicate a general increase in immediate breast reconstruction across various age and racial categories over the years, but its underutilization in the elderly and Asian Americans.\u003c/p\u003e \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003eComparison of patients with and without PMIBR in Korea (AMC-BCR)\u003c/h2\u003e \u003cp\u003eAmong the 13,315 patients who underwent mastectomy, 5,559 (41.7%) received PMIBR. The demographic and clinical parameters of patients who received PMIBR (PMIBR group) versus those who did not (TM only group) were compared in Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e. There were more patients aged\u0026thinsp;\u0026ge;\u0026thinsp;60 years in the TM only group than in the PMIBR group (26.1% vs.4.5%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001). Living in a metropolitan area (46.6% vs. 49.4%, p\u0026thinsp;=\u0026thinsp;0.001), having higher education (66.3% vs. 93.2%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001), being unmarried (5.1% vs. 12.5%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001), having no history of childbirth (6.3% vs. 10.5%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001), and having lower stage and hormone receptor-positive HER2-negative breast cancer were more prevalent variables in the PMIBR group than in the TM only group.\u003c/p\u003e \u003c/div\u003e\n\u003ch3\u003eComparison of younger (\u003c 60) and older (≥ 60) patients who received PMIBR in Korea (AMC-BCR)\u003c/h3\u003e\n\u003cp\u003eAmong 5,601 patients who underwent PMIBR, 95.5% were \u0026lt;\u0026thinsp;60 years, while 4.5% were \u0026ge;\u0026thinsp;60 years. Body mass index (BMI) was significantly lower in younger patients than in older patients (mean BMI: 23.9\u0026thinsp;\u0026plusmn;\u0026thinsp;9.4 vs. 25.7\u0026thinsp;\u0026plusmn;\u0026thinsp;9.7, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001).\u003c/p\u003e \u003cp\u003eWhen the demographic and clinical parameters were compared between younger and older patients, the most common factors in patients with reconstruction were all more common in the younger age group (Table\u0026nbsp;\u003cspan refid=\"Tab2\" class=\"InternalRef\"\u003e2\u003c/span\u003e). Younger patients had higher education levels (94.3% vs. 64.4%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001), underwent axillary lymph node dissection more (37.6% vs. 21.1%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001), and had higher T and N stage. The older group had a higher proportion of married patients (97.6% vs. 87.0%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001) and birth history (91.5% vs. 89.4%, p\u0026thinsp;=\u0026thinsp;0.001) than the younger group. Nipple sparing mastectomy (NSM) was more frequently performed in the younger group, whereas the older group more often underwent skin sparing mastectomy (SSM) (NSM, 54.8% vs. 48.4%; SSM, 44.3% vs. 51.2%, p\u0026thinsp;=\u0026thinsp;0.024).\u003c/p\u003e\n\u003ch3\u003eDemographics and tumor characteristics of women receiving breast reconstruction in Americans\u003c/h3\u003e\n\u003cp\u003eIn the NCDB, Asian Americans had the lowest breast reconstruction rate (3.79%) compared to white (77.76%), black (10.20%), and Hispanic Americans (6.42%). Patients receiving PMIBR were more likely to be white or non-Asian, have higher income and education, reside in a metropolitan area and in the Northeast, have less comorbidities, be treated in an academic center, and have a luminal subtype and lower stage. Additionally, patients with private health insurance were much more likely to undergo reconstruction (Table\u0026nbsp;\u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e3\u003c/span\u003e).\u003c/p\u003e \u003cdiv id=\"Sec11\" class=\"Section2\"\u003e \u003ch2\u003eComorbidities and complications of immediate reconstruction\u003c/h2\u003e \u003cp\u003eA total of 797 patients who received PMIBR with direct implant were examined (Table\u0026nbsp;\u003cspan refid=\"Tab4\" class=\"InternalRef\"\u003e4\u003c/span\u003e). The prevalence of comorbidities and complication rates were reviewed. Hypertension was more prevalent in the older group (\u0026ge;\u0026thinsp;60 years) than in the younger group (\u0026lt;\u0026thinsp;60 years) (31.5% vs. 6.2%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001). Diabetes and dyslipidemia was also more prevalent in the older group than in the younger group (diabetes, 13.7% vs. 1.9%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001; dyslipidemia, 11.1% vs. 2.0%, p\u0026thinsp;=\u0026thinsp;0.002).\u003c/p\u003e \u003cp\u003eRegarding complications, seroma was more frequent in the older group than in the younger group (22.2% vs. 8.1%, p\u0026thinsp;=\u0026thinsp;0.002), which was the only statistically significant difference between the two age groups among patients who had PMIBR with direct implant.\u003c/p\u003e \u003cp\u003eA total of 872 patients who received PMIBR with DIEP were analyzed (Table\u0026nbsp;\u003cspan refid=\"Tab5\" class=\"InternalRef\"\u003e5\u003c/span\u003e). Hypertension was more frequent in the older group than in the younger group (27.9% vs. 7.2%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001). In the early complication category, hematoma showed elevated prevalence rates in the older group (14.0% vs. 5.8%, p\u0026thinsp;=\u0026thinsp;0.030). In the late complication category, fat necrosis was more prevalent in the older group than in the younger group (25.6% vs. 11.6%, p\u0026thinsp;=\u0026thinsp;0.011).\u003c/p\u003e \u003c/div\u003e"},{"header":"Discussion","content":"\u003cp\u003eIn this study, increasing trends of PMIBR rates and underutilization of PMIBR in older patients were observed over the last 20 years using two large cohorts in Korea and the U.S. Patient demographics and clinical parameters associated with the reconstruction recipients were also associated with the younger group compared to older group. Although a higher proportion of hypertension was observed in older patients, detrimetal complications, such as implant rupture, flap necrosis, and graft loss incidence, were similar between younger and older patients.\u003c/p\u003e \u003cp\u003eThe increasing trends of PMIBR align with findings from other studies. In a national database study of Australia, 41,880 women underwent mastectomy between 2010 and 2019, and breast reconstruction rates increased from 12.8\u0026ndash;29% [\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e]. The increasing recognition of improved patient-reported outcomes, advancements in surgical techniques, and greater patient awareness all contribute to the rising popularity of breast reconstruction [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eIn the U.S., the rise in PMBR followed the enactment of the Women\u0026rsquo;s Health \u0026amp; Cancer Rights Act in 1998, which mandated insurance coverage for reconstruction and symmetry procedures [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e]. In Korea, the National Health Insurance Service began covering autologous and implant reconstructions, nipple-areolar complex reconstructions, and additional operations required due to post-reconstruction complications or deformities since 2015. This public single-payer system led to notable increase in PMBR rates from 19.4% in 2015 to 53.4% in 2018 [\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e]. The differing timing of insurance likely explains the slight discrepancy in trends: in the NCDB, PMIBR rates plateaued for Asian and Non-Asian patients aged\u0026thinsp;\u0026lt;\u0026thinsp;60 years in 2015, whereas in Korea, they continued to rise.\u003c/p\u003e \u003cp\u003eSuggested reasons for theunderutilization of PMIBR in the older population include the absence of established treatment protocols, concerns about higher surgical risk, insufficient evidence on outcomes, and limited involvement of older-patients in the decision-making process [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. A British review identified a woman's age as the most important factor in determining whether she will be offered PMBR. Older patients were less likely to be offered and choose to undergo reconstruction [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. Owing to their under-representation in major clinical trials, older patients may receive either insufficient or excessive treatment. Efforts have recently been made to include or specifically focus on the older patients in clinical trials [\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e]. While these trials will undoubtedly contribute to informed oncologic decision-making for the elderly, there remains a need for more evidence and attention regarding surgical management, including breast reconstruction.\u003c/p\u003e \u003cp\u003eIn the review of five other studies comparing PMBR outcomes in older and younger patients, older patients had higher American Society of Anesthesiologists grades, a higher prevalence of hypertension, and a higher average BMI than younger patients. However, no difference was observed in hospital administration days, medical and surgical complication rates, and re-operations or revisions rates between older and younger patients. Older patients exhibited superior post-surgery overall QOL outcomes compared to their age-matched counterparts in the general population and patients who underwent mastectomy without reconstruction [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. In another study reviewing more than 20 studies analyzing breast reconstruction in older women, the complication rates and patient-reported outcomes were not worse than those of younger women [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. An emerging consensus exists that chronological age should not be a barrier to reconstruction [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. Assessing function rather than focusing solely on chronological age has emerged as the most appropriate way to predict surgical outcomes in elderly patients, given their diverse range of physical conditions, capabilities, and expectations [\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e, \u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eThe disparities in PMIBR by age is influenced not only by lower proposal of the procedure by physicians but also factors such as awareness of the procedure, socioeconomic disadvantages, and systemic biases, which restrict healthcare access. Systemic biases are associated with residential regions, education levels, incomes, hospital types, and insurance types, which all vary by race and ethnicity. In Australia, breast reconstruction was less frequently performed in patients living in remote areas but more frequently performed in private hospitals [\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e]. In America, research indicated that large teaching-oriented and urban hospitals in the Northeast provided immediate breast reconstruction more [\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e]. Some experts suggest that a shortage of reconstructive surgeons in the Southern regions contributes to this regional variation [\u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e]. A study investigating barriers to breast reconstruction in rural areas found that 21% of residents in upstate New York reside in counties without access to any form of breast reconstruction, and 44% in counties without access to microsurgical reconstruction [\u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e]. In an observational cohort study examining the effect of insurance status on breast reconstruction rates, patients without health insurance or with government insurance (Medicare, Medicaid) were less likely to undergo breast reconstruction than those with private insurance [\u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eNevertheless, it is important to highlight that Asian Americans exhibit lower PMIBR rates than non-Asian Americans and even lower rates than Korean patients in the AMC-BCR, despite having a higher median household income on average compared to the general U.S. population [\u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e39\u003c/span\u003e]. The substantial underutilization of breast reconstruction in Asian Americans may be attributed to the fact that nearly half of Asian Americans reside in the Western region, where reconstruction procedures are less frequently performed [\u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e40\u003c/span\u003e]. Moreover, it should be considered that AMC might not fully represent the entire Korean population as it is one of the large volume centers located in the metropolitan area, actively engaging in academic research with access to microsurgery. Assuming a setting without regional limitations, insurance issues, communication barriers, or cultural differences, and with active consultation, Asian Americans could be more likely to opt for PMIBR. In a targeted review of the literature summarizing racial disparities in breast reconstruction for African American women, not only access to the procedure but also, comorbidities, outcomes, and literacy about reconstructive options differed [\u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e]. A few studies have evaluated the effects of language barriers in patient-centered breast cancer care and decision-making. From a survey, physicians found it challenging, and in another study, patients felt disrespected and lacked clarity [\u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e42\u003c/span\u003e, \u003cspan citationid=\"CR43\" class=\"CitationRef\"\u003e43\u003c/span\u003e]. While making decisions about breast reconstruction require discussing various options and pros and cons, the present study could provide evidence to possible disparities to Asian Americans by sharing a Korean large center experience.\u003c/p\u003e \u003cp\u003eThe retrospective nature of this study presents a limitation, as it relies on available data and may be susceptible to inherent biases. Although the NCDB lacks comprehensive clinical information, such as breast size, BMI, smoking history, genetic predispositions, and diabetes, it provides valuable information on race, household income, cancer center type, and insurance type, which are not available in the AMC-BCR. Using the datasets and defining the threshold for old age as \u0026ge;\u0026thinsp;60 years, we were able to gather a comparable number of elderly patients who underwent PMIBR and assess their surgical complication rates. Existing literature is limited to small retrospective studies or review articles with heterogeneous age criteria for defining the elderly population. In contrast, our study contributes significantly by providing a homogenous dataset comprising over 5,000 patients who underwent PMIBR at a single center. To overcome these limitations, future research could benefit from prospective designs with predefined protocols, offering a more robust approach to investigate the potential disparities and factors influencing PMBR. Efforts to lower the barrier for older women and Asian Americans and to mitigate disparities should be undertaken with data from further studies.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eBy highlighting trends of PMIBR by age, ethnicity, and culture, we provided additional evidence to the existing literature that PMIBR is underutilized in older patients and Asian Americans. Notable demographic and clinical differences were observed between younger and older patients, with negligible differences in complication rates. Further investigation into the factors contributing to these disparities, along with efforts to mitigate them, is necessary.\u003c/p\u003e "},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that no funds, grants, or other support were received during the preparation of this manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interest\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that they have no conflict of interest.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors contribution\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAll authors contributed to the study conception and design. Material preparation and data collection were performed by Hyun Ho Han, Hyung Bae Kim, Byung Ho Son, Jong Won Lee, Sae Byul Lee, and Hee Jeong Kim. Analysis was performed by Soo-Young Lee and Madhav KC. The first draft of the manuscript was written by Soo-Young Lee and Tristen Park. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. We further confirm that the order of authors listed in the manuscript has been approved by all authors. The authors have no relevant financial or non-financial interests to disclose.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData availability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe datasets analyzed during the current study are not publicly available due to protection of personal information of patients, but are available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthical approval\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent to participate and publish\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eInformed consent was waived because the study was based on retrospective clinical data.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgments\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe would like to thank Editage (www.editage.co.kr) for English language editing.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eSung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71(3), 209\u0026ndash;249.\u003c/li\u003e\n\u003cli\u003eNational Institute of Health. (2023). Surveillance, Epidemiology, and End Results program. SEER Stat Fact Sheets: Female Breast Cancer. Retrieved from http://seer.cancer.gov/statfacts/html/breast.html (Accessed August 19, 2023).\u003c/li\u003e\n\u003cli\u003eEuropean Commission. (2023). Breast cancer statistics, European Cancer Information System. Retrieved from https://ecis.jrc.ec.europa.eu/pdf/Breast_cancer_2022-Oct_2023.pdf\u003c/li\u003e\n\u003cli\u003eYang, H., Ouyang, Q. C., Yan, M., Wang, X. J., Hu, X. C., Jiang, Z. F., et al. (2022). Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China. Annals of Translational Medicine, 10(15), 813. https://doi.org/10.21037/atm-22-302\u003c/li\u003e\n\u003cli\u003eLim YX, Lim ZL, Ho PJ, Li J. (2022). Breast cancer in Asia: incidence, mortality, early detection, mammography programs, and risk-based screening initiatives. Cancers (Basel), 14, 4218.\u003c/li\u003e\n\u003cli\u003eKim MS, Kim SY, Kim JH, Park B, Choi HG. (2017). Depression in breast cancer patients who have undergone mastectomy: A national cohort study. PLOS ONE, 12(4), e0175395. https://doi.org/10.1371/journal.pone.0175395\u003c/li\u003e\n\u003cli\u003eHo SS, So WK, Leung DY, Lai ET, Chan CW. (2013). Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: a comparative evaluation. European Journal of Oncology Nursing, 17(6), 877\u0026ndash;882.\u003c/li\u003e\n\u003cli\u003eKim, M. K., Kim, T., Moon, H. G., Jin, U. S., Kim, K., Kim, J., et al. (2015). Effect of cosmetic outcome on quality of life after breast cancer surgery. European Journal of Surgical Oncology, 41(3), 426\u0026ndash;432. https://doi.org/10.1016/j.ejso.2014.12.002\u003c/li\u003e\n\u003cli\u003eChurilla, T. M., Donnelly, P. E., Leatherman, E. R., Adonizio, C. S., \u0026amp; Peters, C. A. (2015). Total mastectomy or breast conservation therapy? How radiation oncologist accessibility determines treatment choice and quality: a SEER database analysis. The Breast Journal, 21(5), 473\u0026ndash;480.\u003c/li\u003e\n\u003cli\u003eThakur, M., et al. (2023). Psychological distress and body image disturbances after modified radical mastectomy among breast cancer survivors: A cross-sectional study from a tertiary care centre in North India. The Lancet Regional Health - Southeast Asia, 7, 100077.\u003c/li\u003e\n\u003cli\u003eBellino S, Fenocchio M, Zizza M, et al. (2011). Quality of life of patients who undergo breast reconstruction after mastectomy: effects of personality characteristics. Plastic and Reconstructive Surgery, 127(1), 10\u0026ndash;17. https://doi.org/10.1097/PRS.0b013e3181f956c0\u003c/li\u003e\n\u003cli\u003eFern\u0026aacute;ndez-Delgado J, L\u0026oacute;pez-Pedraza MJ, Blasco JA, et al. (2008). Satisfaction with and psychological impact of immediate and deferred breast reconstruction. Annals of Oncology, 19(8), 1430\u0026ndash;1434. https://doi.org/10.1093/annonc/mdn153\u003c/li\u003e\n\u003cli\u003eRubino C, Figus A, Lorettu L, et al. (2007). Post-mastectomy reconstruction: a comparative analysis on psychosocial and psychopathological outcomes. Journal of Plastic, Reconstructive \u0026amp; Aesthetic Surgery, 60(5), 509\u0026ndash;518. https://doi.org/10.1016/j.bjps.2006.06.013\u003c/li\u003e\n\u003cli\u003eLee, R. X. N., Cardoso, M. J., Cheung, K. L., \u0026amp; Parks, R. M. (2022). Immediate breast reconstruction uptake in older women with primary breast cancer: a systematic review. The British Journal of Surgery, 109(11), 1063\u0026ndash;1072. https://doi.org/10.1093/bjs/znac251\u003c/li\u003e\n\u003cli\u003eJeevan, R., Browne, J. P., Gulliver-Clarke, C., et al. (2017). Association between age and access to immediate breast reconstruction in women undergoing mastectomy for breast cancer. Journal of British Surgery, 104(5), 555\u0026ndash;561.\u003c/li\u003e\n\u003cli\u003eKruper, L., Holt, A., Xu, X. X., et al. (2011). Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California. Annals of Surgical Oncology, 18, 2158\u0026ndash;2165.\u003c/li\u003e\n\u003cli\u003eMorrow M, Scott SK, Menck HR, et al. (2001). Factors influencing the use of breast reconstruction post-mastectomy: a national cancer database study. Journal of the American College of Surgeons, 192, 1\u0026ndash;8.\u003c/li\u003e\n\u003cli\u003eTakahashi M, Kai I, Hisata M, et al. (2006). The association between breast surgeons\u0026rsquo; attitudes toward breast reconstruction and their reconstruction-related information-giving behaviors: a nationwide survey in Japan. Plastic and Reconstructive Surgery, 118(6), 1507\u0026ndash;1514.\u003c/li\u003e\n\u003cli\u003eBowman CC, Lennox PA, Clugston PA, Courtemanche DJ. (2006). Breast reconstruction in older women: should age be an exclusion criterion? Plastic and Reconstructive Surgery, 118(1), 16\u0026ndash;22.\u003c/li\u003e\n\u003cli\u003eMacmillan, R. D., \u0026amp; McCulley, S. J. (2016). Oncoplastic breast surgery: what, when and for whom? Current Breast Cancer Reports, 8, 112\u0026ndash;117.\u003c/li\u003e\n\u003cli\u003eSantosa, K. B., Qi, J., Kim, H. M., et al. (2016). Effect of patient age on outcomes in breast reconstruction: Results from a multicenter prospective study. Journal of the American College of Surgeons, 223(6), 745\u0026ndash;754. https://doi.org/10.1016/j.jamcollsurg.2016.09.003\u003c/li\u003e\n\u003cli\u003eMavioso, Carlos, Claudia Pereira, \u0026amp; Maria Joao Cardoso. (2023) Oncoplastic surgery and breast reconstruction in the elderly: an unsolved conundrum. \u003cem\u003eAnnals of Breast Surgery\u003c/em\u003e [Online], 7: n. pag. Web. 13 Feb. 2025\u003c/li\u003e\n\u003cli\u003eBiganzoli L, Battisti NML, Wildiers H, et al. (2021). Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol, 22, e32.\u003c/li\u003e\n\u003cli\u003eHo JY, Hendi AS. (2018). Recent trends in life expectancy across high-income countries: retrospective observational study. BMJ, 362, k2562.\u003c/li\u003e\n\u003cli\u003eKim MS, Kim SY, Kim JH, Park B, Choi HG. (2017). Depression in breast cancer patients who have undergone mastectomy: A national cohort study. PLOS ONE, 12(4), e0175395. https://doi.org/10.1371/journal.pone.0175395\u003c/li\u003e\n\u003cli\u003eSuppli, N. P., Johansen, C., Christensen, J., Kessing, L. V., Kroman, N., \u0026amp; Dalton, S. O. (2014). Increased risk for depression after breast cancer: a nationwide population-based cohort study of associated factors in Denmark, 1998-2011. Journal of Clinical Oncology, 32(34), 3831-3839.\u003c/li\u003e\n\u003cli\u003eHung YP, Liu CJ, Tsai CF, Hung MH, Tzeng CH, Liu CY, et al. (2013). Incidence and risk of mood disorders in patients with breast cancers in Taiwan: a nationwide population-based study. Psycho-oncology, 22(10), 2227\u0026ndash;34. https://doi.org/10.1002/pon.3277\u003c/li\u003e\n\u003cli\u003eJames, R., McCulley, S. J., \u0026amp; Macmillan, R. D. (2015). Oncoplastic and reconstructive breast surgery in the elderly. Journal of British Surgery, 102(5), 480-488.\u003c/li\u003e\n\u003cli\u003ePanchal, H., \u0026amp; Matros, E. (2017). Current Trends in Postmastectomy Breast Reconstruction. Plastic and Reconstructive Surgery, 140(5S), 7S\u0026ndash;13S. https://doi.org/10.1097/PRS.0000000000003941\u003c/li\u003e\n\u003cli\u003eSong, W. J., Kang, S. G., Kim, E. K., Song, S. Y., Lee, J. S., Lee, J. H., \u0026amp; Jin, U. S. (2020). Current status of and trends in post-mastectomy breast reconstruction in Korea. Archives of Plastic Surgery, 47(2), 118\u0026ndash;125. https://doi.org/10.5999/aps.2019.01676\u003c/li\u003e\n\u003cli\u003eKunkler IH, Williams LJ, Jack WJ, et al. (2015). Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomized controlled trial. Lancet Oncol, 16, 266-73.\u003c/li\u003e\n\u003cli\u003eLindgren, B. (2016).The Rise in Life Expectancy, Health Trends among the Elderly, and the Demand for Care - A Selected Literature Review (Working Paper No. 22521). National Bureau of Economic Research. DOI: 10.3386/w22521\u003c/li\u003e\n\u003cli\u003eMuss, H. B., \u0026amp; Busby-Whitehead, J. (2011). Older women with breast cancer: slow progress, great opportunity, now is the time. \u003cem\u003eJournal of clinical oncology : official journal of the American Society of Clinical Oncology\u003c/em\u003e, \u003cem\u003e29\u003c/em\u003e(35), 4608\u0026ndash;4610. https://doi.org/10.1200/JCO.2011.38.6888\u003c/li\u003e\n\u003cli\u003eDayaratna, N., Nguyen, C. L., Spillane, A., Mak, C., Warrier, S. K., \u0026amp; Dusseldorp, J. R. (2023). Trends and variations in post-mastectomy breast reconstruction rates in Australia over 10\u0026thinsp;years. \u003cem\u003eANZ journal of surgery\u003c/em\u003e, \u003cem\u003e93\u003c/em\u003e(1-2), 242\u0026ndash;250. https://doi.org/10.1111/ans.18243\u003c/li\u003e\n\u003cli\u003eHabermann, E. B., Thomsen, K. M., Hieken, T. J., \u0026amp; Boughey, J. C. (2014). Impact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample. \u003cem\u003eAnnals of surgical oncology\u003c/em\u003e, \u003cem\u003e21\u003c/em\u003e(10), 3290\u0026ndash;3296. https://doi.org/10.1245/s10434-014-3924-y\u003c/li\u003e\n\u003cli\u003eChiu, A. S., Thomas, P., Killelea, B. K., Horowitz, N., Chagpar, A. B., \u0026amp; Lannin, D. R. (2017). Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB). \u003cem\u003eAmerican journal of surgery\u003c/em\u003e, \u003cem\u003e214\u003c/em\u003e(5), 907\u0026ndash;913. https://doi.org/10.1016/j.amjsurg.2017.07.008\u003c/li\u003e\n\u003cli\u003eBhat, D., Heiman, A. J., Talwar, A. A., Dunne, M., Amanjee, K., \u0026amp; Ricci, J. A. (2020). Access to Breast Cancer Treatment and Reconstruction in Rural Populations: Do Women Have a Choice?. \u003cem\u003eThe Journal of surgical research\u003c/em\u003e, \u003cem\u003e254\u003c/em\u003e, 223\u0026ndash;231. https://doi.org/10.1016/j.jss.2020.04.035\u003c/li\u003e\n\u003cli\u003eFriedman-Eldar, O., Burke, J., de Castro Silva, I. \u003cem\u003eet al.\u003c/em\u003e (2022). Stalled at the intersection: insurance status and disparities in post-mastectomy breast reconstruction. \u003cem\u003eBreast Cancer Res Treat\u003c/em\u003e\u003cstrong\u003e194\u003c/strong\u003e, 327\u0026ndash;335 . https://doi.org/10.1007/s10549-022-06639-8\u003c/li\u003e\n\u003cli\u003eAmerican Community Survey (2021). \u0026quot;S0201: Selected Population Profile in the United States\u0026quot;. American Community Survey 2021. United States Census Bureau. Retrieved February 8, 202\u003c/li\u003e\n\u003cli\u003eAbby Budiman and Neil G.Ruiz (2021). Key facts about Asian Americans. https://www.pewresearch.org/short-reads/2021/04/29/key-facts-about-asian-americans/ (last updated April 2021)\u003c/li\u003e\n\u003cli\u003eButler, P. D., Morris, M. P., \u0026amp; Momoh, A. O. (2021). Persistent Disparities in Postmastectomy Breast Reconstruction and Strategies for Mitigation. \u003cem\u003eAnnals of surgical oncology\u003c/em\u003e, \u003cem\u003e28\u003c/em\u003e(11), 6099\u0026ndash;6108. https://doi.org/10.1245/s10434-021-10487-z\u003c/li\u003e\n\u003cli\u003eSchapira, M. M., Faghri, A., Jacobs, E. A., Fletcher, K. E., Ganschow, P. S., Gil, D., Smallwood, A. J., Walker, C. M., \u0026amp; Neuner, J. M. (2019). Communication and Shared Decision Making in the Breast Cancer Treatment Consultation: A Comparative Analysis of English- and Spanish-Speaking Patients. MDM policy \u0026amp; practice, 4(2), 2381468319881651. https://doi.org/10.1177/2381468319881651.\u003c/li\u003e\n\u003cli\u003eKarliner, L. S., Hwang, E. S., Nickleach, D., Kaplan, C. P. (2011). Language barriers and patient-centered breast cancer care. Patient Education and Counseling, 84(2), 223-228. https://doi.org/10.1016/j.pec.2010.07.009\u003c/li\u003e\n\u003c/ol\u003e"},{"header":"Tables","content":"\u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003ePatient demographics and tumor characteristics by receipt of breast reconstruction 2001\u0026ndash;2021, AMC-BCR (N\u0026thinsp;=\u0026thinsp;13,315)\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"6\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCharacteristics\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eTotal patients\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eTM only\u003c/p\u003e \u003cp\u003e(N\u0026thinsp;=\u0026thinsp;7,756)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003ePMIBR\u003c/p\u003e \u003cp\u003e(N\u0026thinsp;=\u0026thinsp;5,559)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003ep-value\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAge\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e\u0026lt;60\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e11,042 (82.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e5,734 (73.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e5,308 (95.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e\u0026ge;\u0026thinsp;60\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,273 (17.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e2,022 (26.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e251 (4.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eResidential region\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMetropolitan\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e6,257 (47.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e3,545 (46.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e2,712 (49.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNon-metropolitan\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e6,844 (52.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e4,066 (53.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e2,779 (50.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e214\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eEducation\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHigh school degree\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e8,095 (76.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e4,424 (66.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e3671 (93.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eLess\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,518 (23.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e2,249 (33.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e269 (6.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,702\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMarital status\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eYes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e11,974 (91.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e7,189 (94.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e4,785 (87.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,068 (8.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e3,84 (5.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e684 (12.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e273\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eParity\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMore than one child\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e11,419 (92.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e6,786 (93.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e4,633 (89.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e998 (8.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e453 (6.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e545 (10.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e898\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eStage\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e0\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,203 (9.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e459 (5.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e744 (13.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e1\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e4,4217 (31.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e2,073 (26.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e2,144 (38.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e2\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e5,357 (40.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e3,396 (43.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1,961 (35.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e3\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,538 (19.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e1,828 (23.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e710 (12.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSubtype\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHR+/HER2-\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e6,262 (53.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e3,330 (48.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e2,932 (60.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHR+/HER2+\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,756 (15.1))\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e971 (14.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e785 (16.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHR-/HER2+\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,145 (18.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e1,391 (20.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e754 (15.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHR-/HER2-\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,504 (12.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003e1,136 (16.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e368 (7.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,648\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eAMC-BCR, Asan medical center-breast cancer registry; HR, hormone receptor; HER2, Human epidermal growth factor receptor2\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eComparison of baseline characteristics of young and old patients receiving PMIBR (N\u0026thinsp;=\u0026thinsp;5,559)\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCharacteristics\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eTotal patients\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;5,559\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePatients\u0026thinsp;\u0026lt;\u0026thinsp;60 years old\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;5,308\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003ePatients\u0026thinsp;\u0026ge;\u0026thinsp;60 years old\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;251\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003ep-value\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAge at initial surgery (years), mean\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e44.6\u0026thinsp;\u0026plusmn;\u0026thinsp;8.3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e43.7\u0026thinsp;\u0026plusmn;\u0026thinsp;7.4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e62.9\u0026thinsp;\u0026plusmn;\u0026thinsp;2.9\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eBody mass index (kg/m\u003c/b\u003e\u003csup\u003e\u003cb\u003e2\u003c/b\u003e\u003c/sup\u003e\u003cb\u003e)\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e24.0\u0026thinsp;\u0026plusmn;\u0026thinsp;9.4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e23.9\u0026thinsp;\u0026plusmn;\u0026thinsp;9.4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e25.7\u0026thinsp;\u0026plusmn;\u0026thinsp;9.7\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eResidential region\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.697\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMetropolitan\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,712 (49.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e25,866 (49.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e126 (50.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNon-metropolitan\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,779 (50.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,656 (50.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e123 (49.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e68\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eEducation\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHigh school degree\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,671 (93.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,575 (94.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e96 (64.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eLess\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e269 (6.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e216 (5.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e53 (35.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,619\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMarital status\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eYes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e4,785 (87.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e4543 (87.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e242 (97.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e684 (12.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e678 (13.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e6 (2.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e60\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eParity\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.329\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eYes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e4,633 (89.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e4,417 (89.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e216 (91.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e545 (10.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e525 (10.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e20 (8.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e381\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAxillary staging\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo axillary surgery\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e67 (1.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e66 (1.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (0.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSLNB alone\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,444 (62.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,247 (61.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e197 (78.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAxillary lymph node dissection with/without SLNB\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,048 (36.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,995 (37.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e53 (21.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eClinical T stage T0\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e989 (17.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e920 (17.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e69 (27.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eT1\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,591 (46.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,474 (46.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e117 (46.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eT2\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,619 (29.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,557 (29.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e62 (24.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eT3\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e350 (6.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e347 (6.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e3 (1.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eT4\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e10 (0.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e10 (0.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eClinical N stage N0\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,750 (67.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,550 (66.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e200 (79.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eN1\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,346 (24.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,305 (24.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e41 (16.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eN2\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e344 (6.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e335 (6.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e9 (3.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eN3\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e119 (2.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e118 (2.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (0.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eClinical tumor size (cm)\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2.2\u0026thinsp;\u0026plusmn;\u0026thinsp;2.0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2.2\u0026thinsp;\u0026plusmn;\u0026thinsp;2.1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1.7\u0026thinsp;\u0026plusmn;\u0026thinsp;1.6\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNeoadjuvant chemotherapy Yes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,443 (26.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,931 (74.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e185 (73.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.901\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e4,116 (74.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,377 (25.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e66 (26.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMastectomy type\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.022\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMRM\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e48 (0.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e47 (0.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (0.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSSM\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,479 (44.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2350 (44.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e129 (51.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNSM\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,032 (54.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2911 (54.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e121 (48.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eReconstruction type\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.072\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eImplant\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,771 (31.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1678 (31.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e93 (37.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAutologous\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,788 (68.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3630 (68.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e158 (62.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHistologic grade\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e1\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e245 (5.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e237 (5.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e8 (4.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.519\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e2\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,934 (64.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,818 (64.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e116 (62.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e3\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e136 (30.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,299 (29.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e62 (33.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,019\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNuclear grade\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.639\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e1\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e219 (4.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e208 (4.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e11 (4.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e2\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,394 (65.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,259 (65.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e135 (59.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e3\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,561 (30.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,480 (29.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e81 (35.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e385\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eLymphovascular invasion\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,692 (74.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,491 (73.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e201 (88.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eYes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,276 (25.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,250 (26.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e26 (11.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e591\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHormone receptor\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNegative\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,151 (22.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,074 (21.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e77 (35.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePositive\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e4,052 (77.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,911 (78.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e141 (64.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e356\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHER2\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.233\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNegative\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,300 (63.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,166 (63.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e134 (61.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePositive\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,540 (29.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,464 (29.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e76 (35.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eEquivocal\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e353 (6.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e346 (7.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e7 (3.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e366\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eKi-67\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.002\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e\u0026le;\u0026thinsp;20\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,429 (58.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,325 (58.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e104 (48.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e\u0026gt;\u0026thinsp;20\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,751 (41.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,639 (41.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e112 (51.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,379\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAdjuvant chemotherapy\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.012\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,220 (44.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,113 (44.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e107 (53.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eYes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2,760 (55.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,667 (55.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e93 (46.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e579\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAdjuvant radiotherapy\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.033\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,929 (78.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,759 (78.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e170 (85.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eYes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,050 (21.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,020 (21.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e30 (15.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e580\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAdjuvant endocrine therapy\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1,612 (32.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1,518 (31.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e94 (47.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eYes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,354 (67.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,248 (68.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e106 (53.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e593\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003ePMIBR, postmastectomy immediate breast reconstruction ;SD, standard deviation; SLNB, sentinel lymph node biopsy; MRM, modified radical mastectomy; SSM, skin sparing mastectomy; NSM, nipple sparing mastectomy; HER2, human epidermal growth factor receptor 2\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eDemographics and tumor characteristics of women receiving breast reconstruction by age: NCDB 2004\u0026ndash;2020 (N\u0026thinsp;=\u0026thinsp;966,354)\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eCharacteristics\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eTotal\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;60 years\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003e\u0026ge;\u0026thinsp;60 years\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003ep-value\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003en \u003c/p\u003e \u003cp\u003e(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003en \u003c/p\u003e \u003cp\u003e(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eRace classification 1\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAsian\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e12,588\u003c/p\u003e \u003cp\u003e3.79\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e10,988\u003c/p\u003e \u003cp\u003e87.29\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1,600\u003c/p\u003e \u003cp\u003e12.71\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNon-Asian\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e319,644\u003c/p\u003e \u003cp\u003e96.21\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e248,757\u003c/p\u003e \u003cp\u003e77.82\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e70,887\u003c/p\u003e \u003cp\u003e22.18\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eRace classification 2\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eKorean\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e876\u003c/p\u003e \u003cp\u003e0.26\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e764\u003c/p\u003e \u003cp\u003e87.21\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e112\u003c/p\u003e \u003cp\u003e12.79\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eOther Asians\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e11,712\u003c/p\u003e \u003cp\u003e3.53\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e10,224\u003c/p\u003e \u003cp\u003e87.30\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1,488\u003c/p\u003e \u003cp\u003e12.70\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNon-Asian\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e319,644\u003c/p\u003e \u003cp\u003e96.21\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e248,757\u003c/p\u003e \u003cp\u003e77.82\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e70,887\u003c/p\u003e \u003cp\u003e22.18\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eRace classification 3\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eWhite\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e258,355\u003c/p\u003e \u003cp\u003e77.76\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e198,191\u003c/p\u003e \u003cp\u003e76.71\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e60,164\u003c/p\u003e \u003cp\u003e23.29\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eBlack\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e33,876\u003c/p\u003e \u003cp\u003e10.20\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e27,609\u003c/p\u003e \u003cp\u003e81.50\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e6,267\u003c/p\u003e \u003cp\u003e18.50\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAsian\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e12,588\u003c/p\u003e \u003cp\u003e3.79\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e10,988\u003c/p\u003e \u003cp\u003e87.29\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1,600\u003c/p\u003e \u003cp\u003e12.71\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHispanic\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e21,316\u003c/p\u003e \u003cp\u003e6.42\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e17,910\u003c/p\u003e \u003cp\u003e84.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e3,406\u003c/p\u003e \u003cp\u003e15.98\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNative\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e778\u003c/p\u003e \u003cp\u003e0.23\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e635\u003c/p\u003e \u003cp\u003e81.62\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e143\u003c/p\u003e \u003cp\u003e18.38\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eOther\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e5,319\u003c/p\u003e \u003cp\u003e1.60\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e4,412\u003c/p\u003e \u003cp\u003e82.95\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e907\u003c/p\u003e \u003cp\u003e17.05\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMedian household income\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e\u0026lt;$46,277\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e29,702\u003c/p\u003e \u003cp\u003e8.94\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e22,672\u003c/p\u003e \u003cp\u003e76.33 (9.98)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e7,030\u003c/p\u003e \u003cp\u003e23.67 (11.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e$46,277\u0026ndash;$57,856\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e47,588\u003c/p\u003e \u003cp\u003e14.32\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e36,389\u003c/p\u003e \u003cp\u003e76.47 (16.02)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e11,199\u003c/p\u003e \u003cp\u003e23.53 (17.87)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e$57,857\u0026ndash;$74,062\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e65,469\u003c/p\u003e \u003cp\u003e19.71\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e50,715\u003c/p\u003e \u003cp\u003e77.46 (22.32)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e14,754\u003c/p\u003e \u003cp\u003e22.54 (23.55)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e$74,063+\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e14,7079\u003c/p\u003e \u003cp\u003e44.27\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e117,413\u003c/p\u003e \u003cp\u003e79.83 (51.68)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e29,666\u003c/p\u003e \u003cp\u003e20.17 (47.35)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e42,394\u003c/p\u003e \u003cp\u003e12.76\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e32,556\u003c/p\u003e \u003cp\u003e76.79\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e9,838\u003c/p\u003e \u003cp\u003e23.21\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHigh school degree (%)\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e\u0026ge;15.3%\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e42,859\u003c/p\u003e \u003cp\u003e12.90\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e33,423\u003c/p\u003e \u003cp\u003e77.98\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e9,436\u003c/p\u003e \u003cp\u003e22.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e9.1\u0026ndash;15.2%\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e69,137\u003c/p\u003e \u003cp\u003e20.81\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e53,593\u003c/p\u003e \u003cp\u003e77.52\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e15,544\u003c/p\u003e \u003cp\u003e22.48\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e5.0\u0026ndash;9.0%\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e87,943\u003c/p\u003e \u003cp\u003e26.47\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e68,883\u003c/p\u003e \u003cp\u003e78.33\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e19,060\u003c/p\u003e \u003cp\u003e21.67\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e\u0026lt;5.0%\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e90,398\u003c/p\u003e \u003cp\u003e27.21\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e71,646\u003c/p\u003e \u003cp\u003e79.26\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e18,752\u003c/p\u003e \u003cp\u003e20.74\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e41,895\u003c/p\u003e \u003cp\u003e12.61\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e32,200\u003c/p\u003e \u003cp\u003e76.86\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e9,695\u003c/p\u003e \u003cp\u003e23.14\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUrban/Rural\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMetro\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e290,660\u003c/p\u003e \u003cp\u003e87.49\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e227,884\u003c/p\u003e \u003cp\u003e78.40\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e62,776\u003c/p\u003e \u003cp\u003e21.60\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUrban\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e27,866\u003c/p\u003e \u003cp\u003e8.39\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e21,133\u003c/p\u003e \u003cp\u003e75.84 (8.40)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e6,733\u003c/p\u003e \u003cp\u003e24.16 (9.56)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eRural\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,413\u003c/p\u003e \u003cp\u003e1.03\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,524\u003c/p\u003e \u003cp\u003e73.95 (1.00)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e889\u003c/p\u003e \u003cp\u003e26.05 (1.26)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e10,293\u003c/p\u003e \u003cp\u003e3.10\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e8,204\u003c/p\u003e \u003cp\u003e79.70\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2,089\u003c/p\u003e \u003cp\u003e20.30\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCancer center type\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCommunity\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e10,937\u003c/p\u003e \u003cp\u003e3.29\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e7,981\u003c/p\u003e \u003cp\u003e72.97\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2,956\u003c/p\u003e \u003cp\u003e27.03\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eComprehensive\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e108,821\u003c/p\u003e \u003cp\u003e32.75\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e79,591\u003c/p\u003e \u003cp\u003e73.14\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e29,230\u003c/p\u003e \u003cp\u003e26.86\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAcademic\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e97,066\u003c/p\u003e \u003cp\u003e29.22\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e74,412\u003c/p\u003e \u003cp\u003e76.66\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e22,654\u003c/p\u003e \u003cp\u003e23.34\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eIntegrated network\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e70,259\u003c/p\u003e \u003cp\u003e21.15\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e52,612\u003c/p\u003e \u003cp\u003e74.88\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e17,647\u003c/p\u003e \u003cp\u003e25.12\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e45,149\u003c/p\u003e \u003cp\u003e13.59\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e45,149\u003c/p\u003e \u003cp\u003e100.00\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003cp\u003e0.00\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCancer center location\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNortheast\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e64,563\u003c/p\u003e \u003cp\u003e19.43\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e49,816\u003c/p\u003e \u003cp\u003e77.16 (23.21)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e14,747\u003c/p\u003e \u003cp\u003e22.84 (20.34)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMidwest\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e71,915\u003c/p\u003e \u003cp\u003e21.65\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e54,729\u003c/p\u003e \u003cp\u003e76.10 (25.50)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e17,186\u003c/p\u003e \u003cp\u003e23.90 (23.71)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSouth\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e107,632\u003c/p\u003e \u003cp\u003e32.40\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e78,198\u003c/p\u003e \u003cp\u003e72.65 (36.44)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e29,434\u003c/p\u003e \u003cp\u003e27.35 (37.85)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eWest\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e42,973\u003c/p\u003e \u003cp\u003e12.93\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e31,853\u003c/p\u003e \u003cp\u003e74.12 (14.84)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e11,120\u003c/p\u003e \u003cp\u003e25.88 (15.34)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e45,149\u003c/p\u003e \u003cp\u003e13.59\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e45,149\u003c/p\u003e \u003cp\u003e100.00\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003cp\u003e0.00\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMulti facility treatment\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e245,543\u003c/p\u003e \u003cp\u003e73.91\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e190,871\u003c/p\u003e \u003cp\u003e77.73\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e54,672\u003c/p\u003e \u003cp\u003e22.27\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eYes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e86,689\u003c/p\u003e \u003cp\u003e26.09\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e68,874\u003c/p\u003e \u003cp\u003e79.45\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e17,815\u003c/p\u003e \u003cp\u003e20.55\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCharlson Deyo score\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e0\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e295,930\u003c/p\u003e \u003cp\u003e89.07\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e235,791\u003c/p\u003e \u003cp\u003e79.68\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e60,139\u003c/p\u003e \u003cp\u003e20.32\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e1\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e30,904\u003c/p\u003e \u003cp\u003e9.30\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e20,964\u003c/p\u003e \u003cp\u003e67.84\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e9,940\u003c/p\u003e \u003cp\u003e32.16\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e2+\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e5,398\u003c/p\u003e \u003cp\u003e1.62\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,990\u003c/p\u003e \u003cp\u003e55.39\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2,408\u003c/p\u003e \u003cp\u003e44.61\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eInsurance status\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePrivate\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e260,912\u003c/p\u003e \u003cp\u003e78.53\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e225,820\u003c/p\u003e \u003cp\u003e86.55\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e35,092\u003c/p\u003e \u003cp\u003e13.45\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMedicaid\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e20,132\u003c/p\u003e \u003cp\u003e6.06\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e18,161\u003c/p\u003e \u003cp\u003e90.21\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1,971\u003c/p\u003e \u003cp\u003e9.79\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eMedicare\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e39,304\u003c/p\u003e \u003cp\u003e11.83\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e5,779\u003c/p\u003e \u003cp\u003e14.70\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e33,525\u003c/p\u003e \u003cp\u003e85.30\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eOther Goverment\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e4,283\u003c/p\u003e \u003cp\u003e1.29\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,537\u003c/p\u003e \u003cp\u003e82.58\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e746\u003c/p\u003e \u003cp\u003e17.42\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo insurance\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e4,430\u003c/p\u003e \u003cp\u003e1.33\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3,929\u003c/p\u003e \u003cp\u003e88.69\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e501\u003c/p\u003e \u003cp\u003e11.31\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3,171\u003c/p\u003e \u003cp\u003e0.95\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2,519\u003c/p\u003e \u003cp\u003e79.44\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e652\u003c/p\u003e \u003cp\u003e20.56\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eStage\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003e0\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e64,882\u003c/p\u003e \u003cp\u003e19.53\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e51,159\u003c/p\u003e \u003cp\u003e78.85\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e13,723\u003c/p\u003e \u003cp\u003e21.15\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eI\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e132,385\u003c/p\u003e \u003cp\u003e39.8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e100,373\u003c/p\u003e \u003cp\u003e75.82\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e32,012\u003c/p\u003e \u003cp\u003e24.18\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eII\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e98,665\u003c/p\u003e \u003cp\u003e29.70\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e78,931\u003c/p\u003e \u003cp\u003e80.00\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e19,734\u003c/p\u003e \u003cp\u003e20.00\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eIII\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e36,300\u003c/p\u003e \u003cp\u003e10.93\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e29,282\u003c/p\u003e \u003cp\u003e80.67\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e7,018\u003c/p\u003e \u003cp\u003e19.33\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSubtype\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eER/PR+, HER2-\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e144,018\u003c/p\u003e \u003cp\u003e43.35\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e107,733\u003c/p\u003e \u003cp\u003e74.81\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e36,285\u003c/p\u003e \u003cp\u003e25.19\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.0001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eER/PR+, HER2+\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e28,376\u003c/p\u003e \u003cp\u003e8.54\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e23,632\u003c/p\u003e \u003cp\u003e83.28\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e4,744\u003c/p\u003e \u003cp\u003e16.72\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eER/PR-, HER2+\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e12,634\u003c/p\u003e \u003cp\u003e3.80\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e10,254\u003c/p\u003e \u003cp\u003e81.16\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2,380\u003c/p\u003e \u003cp\u003e18.84\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eER/PR-, HER2 -\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e25,737\u003c/p\u003e \u003cp\u003e7.75\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e21,296\u003c/p\u003e \u003cp\u003e82.74\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e4,441\u003c/p\u003e \u003cp\u003e17.26\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eUnknown\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e121,467\u003c/p\u003e \u003cp\u003e36.56\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e96,830\u003c/p\u003e \u003cp\u003e79.72\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e24,637\u003c/p\u003e \u003cp\u003e20.28\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eNCDB, national cancer database; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab4\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 4\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eComorbidities and complications of immediate reconstruction with direct implant, AMC-PSR\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eTotal patients\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;797\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePatients\u0026thinsp;\u0026lt;\u0026thinsp;60 years old\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;743\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003ePatients\u0026thinsp;\u0026ge;\u0026thinsp;60 years old\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;54\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003ep-value\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAge\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e44.6\u0026thinsp;\u0026plusmn;\u0026thinsp;9.2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e43.3\u0026thinsp;\u0026plusmn;\u0026thinsp;7.8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e63.6\u0026thinsp;\u0026plusmn;\u0026thinsp;3.0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eComorbidities\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHypertension\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e63 (7.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e46 (6.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e17 (31.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eDiabetes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e21 (2.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e14 (1.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e7 (13.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCAD\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e3 (0.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3 (0.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.640\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePVD\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eDyslipidemia\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e21 (2.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e15 (2.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e6 (11.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.002\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCurrent smoking\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e18 (2.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e17 (2.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (1.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.835\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eBreast operation type\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.026\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNSM\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e602 (75.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e568 (76.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e34 (63.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSSM\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e195 (24.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e175 (23.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e20 (37.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eEarly complication\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHematoma\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e20 (2.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e20 (2.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.222\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSeroma\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e72 (9.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e60 (8.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e12 (22.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.002\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eInfection\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e35 (4.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e31 (4.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e4 (7.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.263\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eFlap necrosis\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e62 (7.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e56 (7.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e6 (11.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.344\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eWound dehiscence\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e43 (5.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e37 (5.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e6 (11.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.054\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eImplant failure\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e10 (1.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e9 (1.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (1.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.683\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eLate complication\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSeroma\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e9 (1.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e8 (1.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (1.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.603\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eInfection\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e11 (1.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e9 (1.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2 (3.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.130\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCapsular contracture\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e67 (8.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e60 (8.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e7 (13.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.211\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAnimation\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e34 (4.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e32 (4.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2 (3.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.832\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eImplant shift or rotation\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e74 (9.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e72 (9.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2 (3.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.143\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eImplant failure\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e6 (0.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e5 (0.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (1.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.333\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eImplant rupture\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e9 (1.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e9 (1.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.416\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eImplant change\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e15 (1.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e15 (2.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.292\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eAMC-PSR, Asan medical center plastic surgery registry; CAD, coronary artery disease; PAD, peripheral artery disease; NSM, nipple sparing mastectomy; SSM, skin sparing mastectomy\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab5\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 5\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eComorbidities and complications of immediate reconstruction with DIEP, AMC-PSR\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eTotal patients\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;872\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePatients\u0026thinsp;\u0026lt;\u0026thinsp;60 years old\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;829\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003ePatients\u0026thinsp;\u0026ge;\u0026thinsp;60 years old\u003c/p\u003e \u003cp\u003eN\u0026thinsp;=\u0026thinsp;43\u003c/p\u003e \u003cp\u003eN (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003ep-value\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAge\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e46.9\u0026thinsp;\u0026plusmn;\u0026thinsp;7.6\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e46.0\u0026thinsp;\u0026plusmn;\u0026thinsp;6.8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e62.9\u0026thinsp;\u0026plusmn;\u0026thinsp;2.2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eComorbidities\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHypertension\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e72 (8.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e60 (7.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e12 (27.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eDiabetes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e19 (2.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e17 (2.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2 (4.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.255\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCAD\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePVD\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eDyslipidemia\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e23 (2.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e21 (2.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2 (4.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.315\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eCurrent smoking\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e18 (2.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e17 (2.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (2.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.902\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eBreast operation type\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNSM\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e460\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e438 (52.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e22 (51.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.830\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSSM\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e407\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e386 (46.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e21 (48.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eOther\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e5 (0.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eEarly complication\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eEarly revision\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e29 (3.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e28 (3.4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1 (2.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.708\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePartial loss\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1 (0.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1 (0.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.820\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eTotal loss\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e5 (0.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e5 (0.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.610\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eHematoma\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e54 (6.2)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e48 (5.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e6 (14.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.030\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSeroma\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e35 (4.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e31 (3.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e4 (9.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.070\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eInfection\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e8 (0.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e8 (1.0)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.518\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eFlap necrosis\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e114 (13.1)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e106 (12.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e8 (18.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.270\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eWound dehiscence\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e23 (2.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e23 (2.8)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.268\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eLate complication\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eFat necrosis\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e107 (12.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e96 (11.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e11 (25.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.011\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eVolume loss\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e22 (2.5)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e22 (2.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.279\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eFlap contracture or shrinkage\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e14 (1.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e13 (1.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.510\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eDIEP, deep inferior epigastric perforator; AMC-PSR, Asan medical center plastic surgery registry; CAD, coronary artery disease; PAD, peripheral artery disease; NSM, nipple sparing mastectomy; SSM, skin sparing mastectomy\u003c/p\u003e "}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"postmastectomy reconstruction, medical disparity, age disparity, ethnic disparity","lastPublishedDoi":"10.21203/rs.3.rs-6045529/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6045529/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003ePurpose\u003c/h2\u003e \u003cp\u003ePostmastectomy immediate breast reconstruction (PMIBR) rates in breast cancer patients have increased over recent decades but remain less frequently performed and understudied in elderly patients. We aim to evaluate postmastectomy breast reconstruction trends by age in Korea and the United States, highlighting potential disparities related to age, geography and ethnicity.\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e \u003cp\u003eThis is a multi-cohort retrospective study analyzing three databases. The Asan Medical Center-Breast Cancer Registry (AMC-BCR) included 13,654 total mastectomy patients from 2001\u0026ndash;2021. A subset of patients, separately collected as AMC-plastic surgery registry (AMC-PSR) was used to analyze age-related differences in comorbidities and complications. The National Cancer Database (NCDB) included 966,354 total mastectomy patients with stage 0\u0026ndash;3 breast cancer from 2004\u0026ndash;2020.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e \u003cp\u003ePMIBR rates in AMC-BCR increased from 13\u0026ndash;78% in younger patients (\u0026lt;\u0026thinsp;60 years) and from 0\u0026ndash;28% in older patients (\u0026ge;\u0026thinsp;60 years). Patients living in a metropolitan area (49.4% vs. 46.6%, p\u0026thinsp;=\u0026thinsp;0.001), with higher education (93.2% vs. 66.3%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001), unmarried (12.5% vs. 5.1%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001), and with no childbirth history (10.5% vs. 6.3%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.001) were more likely to undergo reconstruction. In the NCDB, the rates were 37% for young (\u0026lt;\u0026thinsp;60) Asian-Americans, 48% for young non-Asians, 14% for older (\u0026ge;\u0026thinsp;60) Asian-Americans, and 24% for older non-Asians in 2020. Asian-Americans had the lowest reconstruction rates across ethnicities. AMC-PSR data showed no significant difference in major complications by age.\u003c/p\u003e\u003ch2\u003eConclusions\u003c/h2\u003e \u003cp\u003eOlder patients exhibited lower reconstruction rates than the younger patients and demographic factors differed between age groups, suggesting disparities by age, ethnicity and cultural factors.\u003c/p\u003e","manuscriptTitle":"Age and Ethnic Disparities in Postmastectomy Immediate Breast Reconstruction: A cohort study from a Korean single center and National Cancer Database","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-02-21 13:39:27","doi":"10.21203/rs.3.rs-6045529/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"1b0b2152-2957-488a-a188-a82f1ea647f3","owner":[],"postedDate":"February 21st, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2025-09-01T00:53:28+00:00","versionOfRecord":[],"versionCreatedAt":"2025-02-21 13:39:27","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-6045529","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6045529","identity":"rs-6045529","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.